# Title

 Food and Drugs. PART 522â€”IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS


# ID

 CFR-2018-title21-vol6.Pt. 522


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(10.0, 'GBP'), (5.5, 'GBP'), (100.0, 'GBP'), (75.0, 'GBP'), (2.2, 'GBP'), (80.0, 'GBP'), (400.0, 'GBP'), (500.0, 'GBP'), (220.0, 'GBP'), (1000.0, 'GBP'), (40.0, 'GBP'), (22.0, 'GBP'), (150.0, 'GBP'), (20.0, 'GBP'), (187.0, 'GBP'), (200.0, 'GBP'), (25.0, 'GBP'), (50.0, 'GBP'), (110.0, 'GBP'), (5.0, 'GBP'), (300.0, 'GBP')]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Constraints | ['least', 'highest', 'no earlier than', 'before', 'exceeds', 'more than', 'within', 'not to exceed', 'greater than', 'maximum of', 'maximum', 'no later than', 'less than', 'after', 'at least', 'exceed', 'minimum', 'prior to', 'no more than']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Duration    | ['42.0 day', '10.0 hour', '28.0 day', '6.0 month', '100.0 day', '30.0 day', '14.0 day', '20.0 minute', '12.0 day', '4.0 month', '4.0 week', '3 quarter', '5.0 minute', '45.0 day', '19.0 day', '26.0 day', '200.0 day', '20.0 month', '5.0 month', '5.0 day', '9.0 day', '3.0 month', '25.0 day', '21.0 day', '5.0 week', '44.0 day', '24.0 hour', '72.0 hour', '56.0 day', '13.0 day', '11.0 day', '60.0 hour', '15.0 minute', '49.0 day', '10.0 day', '8.0 hour', '22.0 day', '48.0 day', '6.0 hour', '9.0 week', '48.0 hour', '3.0 day', '25.0 minute', '24.0 day', '120.0 day', '15.0 second', '6.0 week', '38.0 day', '3.0 week', '33.0 day', '112.0 day', '400.0 day', '10.0 week', '8.0 week', '1.0 week', '40.0 day', '12.0 week', '16.0 day', '126.0 day', '10.0 month', '1.0 minute', '96.0 hour', '2.0 day', '63.0 day', '1 quarter', '1.0 hour', '2.0 hour', '15.0 day', '10.0 minute', '70.0 day', '144.0 hour', '36.0 hour', '20.0 day', '7.0 day', '1 day', '60.0 second', '12.0 hour', '1.0 day', '1.0 month', '4.0 hour', '6.0 day', '2.0 week', '18.0 day', '4.0 day', '35.0 day', '30.0 minute', '150.0 day', '8.0 day', '8.0 minute']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Condition   | ['until', 'unless', 'where', 'as soon as', 'subject to', 'when', 'if']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Entities    | ['Moxidectin', 'Prostalene', 'Fenprostalene', 'Bunostomum', 'Newborn', 'Lambs', 'Detomidine', 'Nematodirus', 'Flumethasone', 'Buprenorphine', 'Erythromycin', 'Tylosin', 'Ivermectin', 'Kanamycin', 'Pegbovigrastim', 'Frequency', 'Lincomycin', 'Bacillus', 'Inject', 'Horses', 'Sulfachlorpyridazine', 'Proteus', 'Carfentanil', 'Cylicocyclus', 'Brucella', 'Gamithromycin', 'Food', 'Oesophagostomum', 'Hyaluronate', 'Imidocarb', 'Haemophilus', 'Leptospirosis', 'Turkey', 'Dosage', 'Enrofloxacin', 'Sulfadimethoxine', 'Single', 'Sometribove', 'Fluprostenol', 'Embutramide', 'Gleptoferron', 'Oxytocin', 'Tulathromycin', 'Carprofen', 'Severe', 'Methylprednisolone', 'Sterile', 'Haemonchus', 'Escherichia', 'Pasteurella', 'Agriculture', 'Mepivacaine', 'Use', 'Nalorphine', 'Therapy', 'Small', 'Dirofilaria', 'Usual', 'Orgotein', 'Spherophorus', 'Florfenicol', 'Triflupromazine', 'Selenium', 'Butamisole', 'Methocarbamol', 'Sulfomyxin', 'Zinc', 'Diatrizoate', 'Chickens', 'Effectiveness', 'Dihydrostreptomycin', 'Lufenuron', 'Arcanobacterium', 'Amikacin', 'Azaperone', 'Alfaxalone', 'Trimethoprim', 'Treatment', 'Approved', 'Bupivacaine', 'Streptococcus', 'Thiopental', 'Tildipirosin', 'Discontinue', 'Luprostiol', 'Furosemide', 'Swine', 'Trichostrongylus', 'Cooperia, Nematodirus, Bunostomum, Oesophagostomum, Chabertia', 'Gentamicin', 'Dogs', 'Delayed', 'Cylicostephanus', 'Tolazoline', 'Babesia', 'Guaifenesin', 'Levamisole', 'Ceftiofur', 'Strongyloides', 'Boldenone', 'Aminopentamide', 'Cloprostenol', 'Salmonella', 'Spectinomycin', 'Pralidoxime', 'Direct', 'Neomycin', 'Dexamethasone', 'Repeat', 'Safety', 'Klebsiella', 'Chorionic', 'Rapid', 'Iron', 'Trenbolone', 'U.S. Department', 'Collect', 'Thiamylal', 'Oxytetracycline', 'Pyrilamine', 'Clodronate', 'Atipamezole', 'Etorphine', 'Uncinaria', 'Fusobacterium', 'Porphyromonas', 'Robenacoxib', 'Solenopotes', 'Bordetella', 'Pentazocine', 'Withdraw', 'Dose', 'Hydrochlorothiazide', 'Limit', 'Bacteroides', 'Danofloxacin', 'Diprenorphine', 'Tiludronate', 'Dictyocaulus', 'Sulfaethoxypyridazine', 'Implant', 'Zeranol', 'Phenylbutazone', 'Doramectin', 'Isoflupredone', 'Promazine', 'Insert', 'Yohimbine', 'Accidental', 'Propiopromazine', 'Distribution', 'Meloxicam', 'Romifidine', 'Doxylamine', 'Baby', 'Adverse', 'U.S.P', 'Hemoglobin', 'Ewes', 'Ascaris', 'Maropitant', 'Chloramphenicol', 'Flunixin', 'Estradiol', 'Xylazine', 'Ethylisobutrazine', 'Droperidol', 'Mannheimia', 'Hyostrongylus', 'Colistimethate', 'Arizona', 'Cooperia', 'Corynebacterium', 'Melatonin', 'Taenia', 'Arsenamide', 'Butorphanol', 'Neostigmine', 'Calves', 'Euthanasia', 'Avoid', 'Indications', 'Injection', 'Pneumonia', 'Dinoprost', 'Praziquantel', 'Naltrexone', 'Abbott', 'Doxapram', 'Serum', 'Betamethasone', 'Cooperia, Nematodirus, Bunostomum, Oesophagostomum', 'Naproxen', 'Ketoprofen', 'Trichostrongylus, Ostertagia', 'Pentobarbital', 'Firocoxib', 'Cattle', 'Oleate', 'Trichuris', 'Porcine', 'Ostertagia', 'Pseudomonas', 'Haematopinus', 'Tilmicosin', 'Melarsomine', 'Etodolac', 'Insulin', 'Dexmedetomidine', 'Ketamine', 'Cervidae', 'Cupric', 'Hypoderma', 'Ampicillin', 'Echinococcus', 'Cefovecin', 'Initial', 'Leptospira', 'Propofol', 'Gonadorelin', 'Actinomyces', 'Amoxicillin', 'Triodontophorus', 'Histophilus', 'Respiratory'] |
| Date        | ['2018-02-04', '2018-01-20', '2018-05-20', '2051-02-01', '2018-10-12', '2018-02-03', '2018-01-03', '2018-12-24', '2006-01-03', '2018-01-10', '2018-01-02', '2018-03-05', '2018-01-04']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |


# Structured Analysis With Context

 


## Money

| Money           | Context                                                                                                                                                                                                                                                                                                                                                    |
|:----------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (10.0, 'GBP')   | Administer by subcutaneous or intramuscular injection every 8 to 12 hours as follows: For animals weighing up to 10 pounds (lbs): 0.1 mg; For animals weighing 11 to 20 lbs: 0.2 mg; For animals weighing 21 to 50 lbs: 0.3 mg; For animals weighing 51 to 100 lbs: 0.4 mg; For animals weighing over 100 lbs: 0.5 mg.                                     |
| (10.0, 'GBP')   | Administer 0.1 milliliter (mL) per pound of body weight (1.0 mL for every 10 pounds) by intravenous injection twice a day for 2 days.                                                                                                                                                                                                                      |
| (80.0, 'GBP')   | For control of aggressiveness when mixing or regrouping weanling or feeder pigs weighing up to 80 pounds.                                                                                                                                                                                                                                                  |
| (20.0, 'GBP')   | Administer by intramuscular injection 0.25 to 0.5 milliliter (mL) per 20 pounds of body weight, depending on the severity of the condition.                                                                                                                                                                                                                |
| (20.0, 'GBP')   | (ii) It is administered by intramuscular injection at a dosage of 0.25 to 0.5 milliliter per 20 pounds of body weight, depending on the severity of the condition.                                                                                                                                                                                         |
| (100.0, 'GBP')  | For general anesthesia: Administer 20 to 50 milliliters per 100 pounds of body weight by intravenous injection until the desired effect is produced.                                                                                                                                                                                                       |
| (300.0, 'GBP')  | 200 milligrams (1 mL) for calves 300 pounds and under; 400 milligrams (2 mL) for calves over 300 pounds and adult cattle.                                                                                                                                                                                                                                  |
| (300.0, 'GBP')  | 200 milligrams (1 mL) for calves 300 pounds and under; 400 milligrams (2 mL) for calves over 300 pounds and adult cattle.                                                                                                                                                                                                                                  |
| (220.0, 'GBP')  | For sedation, analgesia, or sedation and analgesia: 20 or 40 micrograms per kilogram (0.2 or 0.4 milliliter per 100 kilogram or 220 pounds) by body weight, depending on depth and duration required.                                                                                                                                                      |
| (100.0, 'GBP')  | 1 mg per 100 pounds of body weight as a single intramuscular injection.                                                                                                                                                                                                                                                                                    |
| (110.0, 'GBP')  | 200 micrograms per kilogram (10 milligrams per 110 pounds).                                                                                                                                                                                                                                                                                                |
| (75.0, 'GBP')   | 300 micrograms per kilogram (10 milligrams per 75 pounds).                                                                                                                                                                                                                                                                                                 |
| (100, 'GBP')    | (c) Conditions of use&#8212;(1) Amount&#8212;(i) Horses: Administer 25 mg per hundred pounds of body weight by intramuscular, subcutaneous, or slow intravenous injection.                                                                                                                                                                                 |
| (20.0, 'GBP')   | (i) For analgesia and tranquilization, administer as follows:                                                                                                                                                                                                                                                                                              |
|                 |             (A) 1 milliliter (mL) per 15 to 20 pounds (lbs) of body weight by intramuscular injection in conjunction with atropine sulfate administered at the rate of 0.02 mg per pound of body weight; or                                                                                                                                                |
|                 |             (B) 1 mL per 25 to 60 lbs of body weight by intravenous injection in conjunction with atropine sulfate administered at the rate of 0.02 mg per pound of body weight.                                                                                                                                                                           |
| (5.0, 'GBP')    | One mL per 5 pounds of body weight.                                                                                                                                                                                                                                                                                                                        |
| (100.0, 'GBP')  | Use the product described in paragraph (a)(2) of this section as follows:                                                                                                                                                                                                                                                                                  |
|                 |             (i) Amount&#8212;(A) Single-dose therapy: For treatment of bovine respiratory disease (BRD), administer 7.5 to 12.5 mg/kg of body weight (3.4 to 5.7 mL per 100 pounds (/100 lb)) once by subcutaneous injection.                                                                                                                              |
| (400.0, 'GBP')  | For heifers weighing 400 pounds or more; for subcutaneous ear implantation, one dose per animal; not for use in dairy or beef replacement heifers.                                                                                                                                                                                                         |
| (10.0, 'GBP')   | One mL per 10 pounds of body weight.                                                                                                                                                                                                                                                                                                                       |
| (10.0, 'GBP')   | Administer by intramuscular injection as follows: Dogs weighing up to 10 pounds (lbs): 2 mg; dogs weighing 10 to 25 lbs: 4 mg; dogs weighing over 25 lbs: 8 mg.                                                                                                                                                                                            |
| (110.0, 'GBP')  | Administer 6 mg/kilogram of body weight (2 mL per 110 pounds) one time by subcutaneous injection in the neck.                                                                                                                                                                                                                                              |
| (10.0, 'GBP')   | 5 micrograms per pound of body weight (0.25 milliliter per 10 pounds of body weight) by intravenous, intramuscular, or subcutaneous injection in dogs or by intramuscular injection in cats.                                                                                                                                                               |
| (187.0, 'GBP')  | For use only in gilts over 51/2 months of age and weighing at least 85 kilograms (187 pounds).                                                                                                                                                                                                                                                             |
| (300.0, 'GBP')  | The usual dose for a 300-pound animal is 5 mg by intramuscular injection.                                                                                                                                                                                                                                                                                  |
| (110.0, 'GBP')  | Administer 1 mL (10 mg ivermectin and 100 mg clorsulon) per 50 kilograms (110 pounds) by subcutaneous injection.                                                                                                                                                                                                                                           |
| (100.0, 'GBP')  | 2 milliliters per 100 pounds of body weight, subcutaneously in the neck.                                                                                                                                                                                                                                                                                   |
| (2.2, 'GBP')    | Administer 0.2 mg/kg of body weight (0.2 mg/2.2 pound) as a single, subcutaneous injection.                                                                                                                                                                                                                                                                |
| (5.0, 'GBP')    | One milligram per 5 pounds; intravenously, intramuscularly, or subcutaneously.                                                                                                                                                                                                                                                                             |
| (100.0, 'GBP')  | Administer to cattle and horses at a dosage level of 1 mg per (/) 100 pounds (lbs) of body weight subcutaneously.                                                                                                                                                                                                                                          |
| (100.0, 'GBP')  | Only 2 milliliters of the drug should be injected per site in case of calves weighing 100 pounds or less and not more than 10 milliliters should be injected per site in adult cattle.                                                                                                                                                                     |
| (100.0, 'GBP')  | Do not inject more than 10 milliliters per injection site intramuscularly in adult cattle; no more than 1 milliliter per site in calves weighing 100 pounds or less.                                                                                                                                                                                       |
| (100.0, 'GBP')  | In calves weighing 100 pounds or less, do no inject more than 2 milliliters intramuscularly per site.                                                                                                                                                                                                                                                      |
| (100.0, 'GBP')  | In calves weighing 100 pounds or less inject only 2 milliliters per site.                                                                                                                                                                                                                                                                                  |
| (22.0, 'GBP')   | Administer once as an intramuscular or subcutaneous injection of 1 mL per 22 pounds (lb) body weight (BW) (13.6 mg oxytetracycline and 0.9 mg flunixin per lb BW) where retreatment of calves and yearlings for bacterial pneumonia is impractical due to husbandry conditions, such as cattle on range, or where their repeated restraint is inadvisable. |
| (150.0, 'GBP')  | 2 milliliters per 150 pounds of body weight intramuscularly or subcutaneously.                                                                                                                                                                                                                                                                             |
| (150.0, 'GBP')  | 2 milliliters per 150 pounds of body weight intramuscularly.                                                                                                                                                                                                                                                                                               |
| (25.0, 'GBP')   | 1 milliliter per 10 to 25 pounds of body weight intramuscularly or subcutaneously.                                                                                                                                                                                                                                                                         |
| (150.0, 'GBP')  | 2 milliliters per 150 pounds of body weight subcutaneously.                                                                                                                                                                                                                                                                                                |
| (500.0, 'GBP')  | (B) As in paragraph (d)(2)(ii)(A) of this section; and prophylaxis of bovine shipping fever in 300- to 500-pound beef calves.                                                                                                                                                                                                                              |
| (100.0, 'GBP')  | 3,000 units per pound body weight (1 milliliter per 100 pounds body weight) daily by intramuscular injection.                                                                                                                                                                                                                                              |
| (1000.0, 'GBP') | Administer by intravenous injection 1 to 2 grams (g) per 1,000 pounds of body weight daily in three divided doses, not to exceed 4 g daily.                                                                                                                                                                                                                |
| (5.0, 'GBP')    | Administer by subcutaneous or intramuscular injection for dogs and puppies 5 pounds (lb) and under, 0.3 mL; for 6 to 10 lb, 0.5 mL; for 11 to 25 lb, 1.0 mL; if over 25 lb, 0.2 mL/5 lb body weight to a maximum of 3 mL.                                                                                                                                  |
| (5.0, 'GBP')    | (ii) Dogs and cats: Administer by intramuscular injection 1 mg per 5 pounds of body weight or intrasynovially at a dosage level of 10 to 20 mg.                                                                                                                                                                                                            |
| (400.0, 'GBP')  | For use in suckling beef calves (at least 45 days of age) up to 400 pounds (lb) of body weight.                                                                                                                                                                                                                                                            |
| (100.0, 'GBP')  | (c) Conditions of use&#8212;(1) Amount&#8212;(i) Horses, 40 to 60 mg per 100 pounds (lbs) body weight; foals, 20 mg/100 lbs body weight.                                                                                                                                                                                                                   |
| (5.5, 'GBP')    | After the initial subcutaneous dose, subsequent doses can be given by subcutaneous injection or as the oral tablet in dogs weighing at least 5.5 pounds (2.5 kg) and at least 4 months of age, for a maximum of 3 total doses over 3 days, not to exceed 1 dose per day.                                                                                   |
| (100.0, 'GBP')  | Administer 1 milliliter (mL) per (/) 100 pounds (lbs) of body weight by intravenous injection or by deep intramuscular injection in divided doses in two or more sites in the gluteal or cervical muscles.                                                                                                                                                 |
| (100.0, 'GBP')  | Calves: 2.5 to 3.75 milliliters per 100 pounds of body weight.                                                                                                                                                                                                                                                                                             |
| (40.0, 'GBP')   | Lambs 2 weeks of age or older: 1 milliliter per 40 pounds, minimum 1 milliliter.                                                                                                                                                                                                                                                                           |
| (100.0, 'GBP')  | Ewes: 2.5 milliliters per 100 pounds.                                                                                                                                                                                                                                                                                                                      |
| (40.0, 'GBP')   | Sows: 1 milliliter per 40 pounds.                                                                                                                                                                                                                                                                                                                          |
| (40.0, 'GBP')   | Weanling pigs: 1 milliliter per 40 pounds, minimum 1 milliliter.                                                                                                                                                                                                                                                                                           |
| (200.0, 'GBP')  | Breeding beef cows: 1 milliliter per 200 pounds of body weight during the middle third of gestation, and 30 days before calving.                                                                                                                                                                                                                           |
| (200.0, 'GBP')  | Weanling calves: 1 milliliter per 200 pounds of body weight.                                                                                                                                                                                                                                                                                               |
| (100.0, 'GBP')  | Administer 25 mg per 100 pounds of body weight by deep intramuscular injection in the gluteal region at weekly intervals, for not more than 4 weeks.                                                                                                                                                                                                       |
| (100.0, 'GBP')  | Administer 2.5 grams per 100 pounds of body weight per day by intravenous injection for not more than 4 days; or first treatment may be followed by 3 days of treatment with sulfaethoxypyridazine in drinking water or tablets in accordance with &#167;&#167;&#8201;520.2240a(e) and 520.2240b(e) of this chapter.                                       |
| (50.0, 'GBP')   | Initially administer 20 mL for each 50 pounds (lb) of body weight (100 mg/lb) by intravenous injection, followed by 20 mL per 100 lb of body weight (50 mg/lb) by intravenous injection, daily thereafter.                                                                                                                                                 |
| (5.0, 'GBP')    | (ii) Swine: 40 mg per 5 pounds (lbs) of body weight.                                                                                                                                                                                                                                                                                                       |
| (220.0, 'GBP')  | Administer slowly by intravenous injection 4 mg per kilogram of body weight or 1.8 mg per pound (4 milliliters (mL) per 100 kilograms or 4 mL per 220 pounds).                                                                                                                                                                                             |
| (100.0, 'GBP')  | Administer by intravenous or intramuscular injection at a dosage of 10 to 15 mg per 100 pounds of body weight daily to a maximum dose of 100 mg.                                                                                                                                                                                                           |
| (20.0, 'GBP')   | 1 mL of the product described in paragraph (a)(1) of this section (40 mg trimethoprim and 200 mg sulfadiazine) per 20 pounds (9 kilograms) of body weight per day by subcutaneous injection.                                                                                                                                                               |
| (100.0, 'GBP')  | 2 mL of the product described in paragraph (a)(2) of this section (160 mg trimethoprim and 800 mg sulfadiazine) per 100 pounds (45 kilograms) of body weight per day by intravenous injection as single, daily dose for 5 to 7 days.                                                                                                                       |
| (200.0, 'GBP')  | Use a 50-mg/mL solution for calves weighing less than 200 pounds.                                                                                                                                                                                                                                                                                          |


## Constraints

| Constraints     | Context                                                                                                                                                   |
|:----------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------|
| maximum of      | Dosage may be gradually increased up to a  maximum of  five times the suggested dosage.                                                                   |
| after           | day for five treatments beginning about 30 days after  initial injury.                                                                                    |
| after           | for food during treatment and for 25 days after  the last treatment.                                                                                      |
| after           | during treatment or for 96 hours (8 milkings) after  last treatment.                                                                                      |
| after           | food use during treatment or for 9 days after  the last treatment.                                                                                        |
| after           | food use during treatment or for 15 days after  the last treatment.                                                                                       |
| more than       | Do not treat cattle for  more than  7 days.                                                                                                               |
| after           | during treatment and for 48 hours (4 milkings) after  the last treatment.                                                                                 |
| after           | during treatment and for 144 hours (6 days) after  the last treatment.                                                                                    |
| not to exceed   | repeated every 3 weeks or when symptoms recur, not to exceed  a total of four injections.                                                                 |
| not to exceed   | repeated every 3 weeks or when symptoms recur, not to exceed  a total of 4 injections.                                                                    |
| prior to        | Administer the first dose approximately 1 hour  prior to  surgery.                                                                                        |
| after           | a second injection should be given 21 days after  the initial treatment.                                                                                  |
| maximum of      | If necessary, increase dose to a  maximum of  0.05 mg per pound of body weight.                                                                           |
| more than       | Do not treat for  more than  2 days.                                                                                                                      |
| within          | Dose may be repeated  within  3 to 4 hours.                                                                                                               |
| exceed          | Treatment should not  exceed  48 hours.                                                                                                                   |
| before          | Do not use 30 days  before  or during hunting season.                                                                                                     |
| before          | control of postoperative pain, administer approximately 2 hours before  the procedure.                                                                    |
| after           | regimen, a 13-day pre-slaughter withdrawal period is required after  the last treatment.                                                                  |
| after           | repeated every 24 hours, continued for 48 hours after clinical signs have disappeared, and should not exceed                                              |
| exceed          | after clinical signs have disappeared, and should not exceed  10 days.                                                                                    |
| maximum of      | A  maximum of  10 mL should be administered per injection site.                                                                                           |
| maximum         | body weight by intramuscular injection up to a maximum  dose of 900 mg per horse.                                                                         |
| after           | abortion in pregnant feedlot heifers from 1 week after  mating until 41/2 months of gestation.                                                            |
| after           | terminating unwanted pregnancies from mismatings from 1 week after  mating until 5 months                                                                 |
| after           | terminating unwanted pregnancies from mismatings from 1 week after  mating until 5 months                                                                 |
| after           | injection regimen with a second injection 11 days after the first, for scheduling estrus and ovulation to                                                 |
| before          | 6 months in cattle; discontinue use 30 days before treated animals are slaughtered for food use; Federal                                                  |
| within          | intended for human consumption should not be slaughtered within  4 days from the last treatment.                                                          |
| within          | For inducing ovulation  within 48 hours in estrous mares with an ovarian                                                                                  |
| greater than    | hours in estrous mares with an ovarian follicle greater than  30 mL in diameter.                                                                          |
| within          | For inducing ovulation  within 48 hours in cyclic estrous mares with an                                                                                   |
| before          | therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor                                            |
| after           | canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks,                                       |
| maximum of      | (mL) per pound of body weight to a maximum of  30 mL intravenously.                                                                                       |
| at least        | until the urine is free of leptospira for at least  72 hours as measured by darkfield microscopic examination.                                            |
| before          | Discontinue use 30 days  before  slaughter for food.                                                                                                      |
| at least        | having a corpus luteum, i.e., those which ovulated at least  5 days prior to treatment.                                                                   |
| prior to        | i.e., those which ovulated at least 5 days prior to  treatment.                                                                                           |
| within          | For parturition induction in swine when injected  within  3 days of normal predicted farrowing.                                                           |
| before          | Do not use 30 days  before , or during, the hunting season in free-ranging                                                                                |
| after           | Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after  treatment.                                                                        |
| within          | Do not slaughter cattle  within  35 days of treatment.                                                                                                    |
| within          | Do not slaughter swine  within  24 days of treatment.                                                                                                     |
| after           | cats, and horses to stimulate respiration during and after general anesthesia; or to speed awakening and return                                           |
| after           | cats, and horses to stimulate respiration during and after general anesthesia; or to speed awakening and return                                           |
| within          | mg per pound of body weight and followed within 15 seconds by an intravenous administration of sodium                                                     |
| maximum of      | days beyond cessation of clinical signs to a maximum of  10 days.                                                                                         |
| within          | intended for human consumption must not be slaughtered within  28 days from the last treatment.                                                           |
| within          | intended for human consumption must not be slaughtered within  5 days of receiving a single-injection dose.                                               |
| within          | intended for human consumption must not be slaughtered within  48 days of the last treatment.                                                             |
| within          | Do not slaughter treated animals  within  6 days of last treatment.                                                                                       |
| within          | To avoid excess trim, do not slaughter  within  21 days of last injection.                                                                                |
| less than       | milligrams (mg) estradiol and is coated with not less than  0.5 mg oxytetracycline powder.                                                                |
| less than       | additional effectiveness may be expected from reimplanting in less than 200 days for the 25.7-mg implant or 400                                           |
| after           | treated group should be started at 48 hours after the last implant has been removed and should                                                            |
| within          | implant has been removed and should be completed within  6 hours.                                                                                         |
| after           | is preferred, insemination should be approximately 12 hours after  first detection of estrus.                                                             |
| after           | return to estrus approximately 17 to 25 days after  implant removal.                                                                                      |
| after           | of this chapter may be given 24 hours after  the injection.                                                                                               |
| before          | Do not use 30 days  before , or during, the hunting season in free-ranging                                                                                |
| at least        | induction of parturition in sows and gilts pregnant at least  112 days.                                                                                   |
| within          | intended for human consumption must not be slaughtered within  44 days of treatment.                                                                      |
| within          | intended for human consumption must not be slaughtered within  28 days of the last intramuscular treatment.                                               |
| within          | intended for human consumption must not be slaughtered within  33 days of subcutaneous treatment.                                                         |
| within          | intended for human consumption must not be slaughtered within  38 days of treatment.                                                                      |
| exceed          | Dosage by injection should not  exceed  3 days of therapy.                                                                                                |
| within          | Cattle must not be slaughtered for human consumption  within  4 days of last treatment.                                                                   |
| after           | been taken during treatment and for 36 hours after the last treatment must not be used for                                                                |
| within          | Swine must not be slaughtered for human consumption  within  12 days of last treatment.                                                                   |
| not to exceed   | Treatment  not to exceed  48 hours post-parturition.                                                                                                      |
| after           | during treatment and for 48 hours (four milkings) after the last treatment must not be used for                                                           |
| within          | Cattle must not be slaughtered for food  within  48 hours following last treatment.                                                                       |
| within          | intended for human consumption must not be slaughtered within  35 days from the last treatment.                                                           |
| after           | exact dosage to be administered must be determined after evaluating the animal's condition and will vary according                                        |
| after           | daily on the first day, once daily there after , using a 50 milligram-per-milliliter solution.                                                            |
| after           | If response is not noted  after 7 days, the antibiotic sensitivity of the infecting                                                                       |
| at least        | poults must not be slaughtered for food for at least  9 weeks after treatment.                                                                            |
| after           | slaughtered for food for at least 9 weeks after  treatment.                                                                                               |
| at least        | Do not slaughter treated animals for food for  at least  5 weeks after treatment.                                                                         |
| after           | animals for food for at least 5 weeks after  treatment.                                                                                                   |
| at least        | Do not slaughter treated animals for food for  at least  40 days following treatment.                                                                     |
| after           | If no improvement is seen  after 3 days, treatment should be discontinued and the                                                                         |
| not to exceed   | Treatment  not to exceed  7 days.                                                                                                                         |
| before          | iron) per pig by intramuscular injection on or before  3 days of age.                                                                                     |
| at least        | gilts over 51/2 months of age and weighing at least  85 kilograms (187 pounds).                                                                           |
| after           | Delayed return to estrus is most prevalent  after  the first litter.                                                                                      |
| after           | The effectiveness has not been established  after  later litters.                                                                                         |
| exceed          | administered per fish (all injections combined) should not exceed  25,000 IU chorionic gonadotropin.                                                      |
| no earlier than | 0.4 mg (2 milliliter (mL)) by subcutaneous injection no earlier than  9 weeks of age.                                                                     |
| at least        | of 0.4 mg (2 mL) should be administered at least  4 weeks after the first dose.                                                                           |
| after           | mL) should be administered at least 4 weeks after  the first dose.                                                                                        |
| no earlier than | Pigs should be slaughtered  no earlier than 3 weeks and no later than 10 weeks                                                                            |
| no later than   | be slaughtered no earlier than 3 weeks and no later than  10 weeks after the second dose.                                                                 |
| after           | 3 weeks and no later than 10 weeks after  the second dose.                                                                                                |
| after           | Treatment may be repeated  after 1 or more weeks but not to exceed                                                                                        |
| not to exceed   | be repeated after 1 or more weeks but not to exceed 2 injections per week for a total of                                                                  |
| after           | be continued with an orally administered maintenance dose. after                                                                                          |
| after           | during treatment and for 72 hours (6 milkings) after the latest treatment must not be used for                                                            |
| after           | injection in the neck region, repeating dosage once after  24 hours.                                                                                      |
| after           | Repeat the dose  after  2 weeks for a total of two treatments.                                                                                            |
| after           | weight by subcutaneous injection concurrently with or right after  a meal.                                                                                |
| less than       | initiated, the two doses should be 25 percent less than the once daily dose required to attain an                                                         |
| after           | the injections should be concurrent with or right after  a meal.                                                                                          |
| after           | dose should be given concurrently with or right after  a meal.                                                                                            |
| within          | intended for human consumption should not be slaughtered within  7 days of last treatment.                                                                |
| within          | intended for human consumption should not be slaughtered within  7 days of last treatment.                                                                |
| after           | D. viviparus and O. radiatum for 28 days after treatment; O. ostertagi, T. axei, and C. punctata                                                          |
| after           | D. viviparus and O. radiatum for 28 days after treatment; O. ostertagi, T. axei, and C. punctata                                                          |
| after           | D. viviparus and O. radiatum for 28 days after treatment; O. ostertagi, T. axei, and C. punctata                                                          |
| within          | Do not treat cattle  within  35 days of slaughter.                                                                                                        |
| within          | Do not treat swine  within  18 days of slaughter.                                                                                                         |
| within          | Do not slaughter  within  56 days of last treatment.                                                                                                      |
| within          | Do not treat reindeer  within  56 days of slaughter.                                                                                                      |
| after           | T. axei, and C. punctata for 21 days after treatment; and H. placei and C. oncophora for                                                                  |
| after           | T. axei, and C. punctata for 21 days after treatment; and H. placei and C. oncophora for                                                                  |
| within          | For No. 050604: Do not treat cattle  within  21 days of slaughter.                                                                                        |
| within          | 055529 and 058005: Do not treat cattle  within  49 days of slaughter.                                                                                     |
| more than       | Do not administer  more than  10 milliliters per site.                                                                                                    |
| within          | conditions of constant helminth exposure may require re-treatment within  2 to 4 weeks after first treatment.                                             |
| after           | may require re-treatment within 2 to 4 weeks after  first treatment.                                                                                      |
| before          | Consult your veterinarian  before using in severely debilitated animals or animals under                                                                  |
| within          | Do not administer to cattle  within  7 days of slaughter.                                                                                                 |
| within          | Do not treat  within  48 hours of slaughter.                                                                                                              |
| after           | For treatment  after day 1, administer meloxicam suspension orally at 0.045                                                                               |
| prior to        | with orthopedic surgery, ovariohysterectomy, and castration when administered prior to  surgery.                                                          |
| prior to        | as required; for anesthesia of the laryngeal mucosa prior to ventriculectomy, by topical spray, 25 to 40 mL,                                              |
| prior to        | topical and/or infiltration anesthesia of the laryngeal mucosa prior to  ventriculectomy.                                                                 |
| not to exceed   | The total cumulative dose should  not to exceed  150 mg per pound of body weight.                                                                         |
| after           | D. viviparus and O. radiatum for 42 days after  treatment, with H. placei for 35 days                                                                     |
| after           | D. viviparus and O. radiatum for 42 days after  treatment, with H. placei for 35 days                                                                     |
| after           | D. viviparus and O. radiatum for 42 days after  treatment, with H. placei for 35 days                                                                     |
| within          | Do not slaughter cattle  within  21 days of treatment.                                                                                                    |
| before          | not use in free-ranging animals for 45 days before  or during hunting season.                                                                             |
| more than       | Do not inject  more than  2 mL per injection site.                                                                                                        |
| exceed          | injection sites, the total volume used should not exceed  10 mL.                                                                                          |
| after           | 5 mg daily for 6 days, and there after , every other day for 8 days.                                                                                      |
| highest         | Exceeding the  highest recommended level of drug per pound of bodyweight                                                                                  |
| more than       | drug per pound of bodyweight per day, administering more than the recommended number of treatments, and/or exceeding 10                                   |
| at least        | be administered intravenously slowly over a period of at least  5 minutes.                                                                                |
| at least        | Discontinue treatment  at least  28 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 28 days  prior to  slaughter.                                                                                              |
| after           | from animals during treatment and for 96 hours after the last treatment must not be used for                                                              |
| before          | 3 mg/lb BW intramuscularly once, approximately 8 hours before farrowing or immediately after completion of farrowing, as                                  |
| after           | once, approximately 8 hours before farrowing or immediately after completion of farrowing, as an aid in control                                           |
| more than       | Do not inject  more than  5 mL per site in adult swine.                                                                                                   |
| at least        | Discontinue treatment  at least  28 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 28 days  prior to  slaughter.                                                                                              |
| not to exceed   | 48 hours following remission of disease signs, however, not to exceed  a total of four consecutive days.                                                  |
| more than       | Do not inject  more than 10 mL per site in adult cattle, reducing                                                                                         |
| highest         | Exceeding the  highest recommended level of drug/lb BW/day, administering more than                                                                       |
| more than       | the highest recommended level of drug/lb BW/day, administering more than the recommended number of treatments, and/or exceeding 10                        |
| at least        | be administered intravenously slowly over a period of at least  5 minutes.                                                                                |
| at least        | Discontinue treatment  at least  28 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 28 days  prior to  slaughter.                                                                                              |
| before          | 3 mg/lb BW intramuscularly once, approximately 8 hours before farrowing or immediately after completion of farrowing, as                                  |
| after           | once, approximately 8 hours before farrowing or immediately after completion of farrowing, as an aid in control                                           |
| not to exceed   | 48 hours beyond remission of disease signs, however, not to exceed  a total of 4 consecutive days.                                                        |
| highest         | Exceeding the  highest recommended level of drug/lb BW/day, administering more than                                                                       |
| more than       | the highest recommended level of drug/lb BW/day, administering more than the recommended number of treatments, and/or exceeding 5                         |
| at least        | Discontinue treatment  at least  28 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 28 days  prior to  slaughter.                                                                                              |
| not to exceed   | 48 hours following remission of disease symptoms; however, not to exceed  a total of 4 consecutive days.                                                  |
| more than       | calves weighing 100 pounds or less and not more than 10 milliliters should be injected per site in                                                        |
| at least        | (iii) Discontinue treatment with the drug  at least  20 days prior to slaughter of the animal.                                                            |
| prior to        | treatment with the drug at least 20 days prior to  slaughter of the animal.                                                                               |
| within          | When administered to animals  within 30 days of slaughter, muscle discoloration may necessitate                                                           |
| not to exceed   | 48 hours beyond remission of disease symptoms, but not to exceed  a total of 4 consecutive days.                                                          |
| within          | Consult your veterinarian if no improvement is noted  within  48 hours.                                                                                   |
| more than       | Do not inject  more than 10 milliliters per site in adult cattle, reducing                                                                                |
| highest         | Exceeding the  highest recommended dose of 5 milligrams per pound of                                                                                      |
| more than       | of body weight, administering at recommended levels for more than 4 consecutive days, and/or exceeding 10 milliliters intramuscularly                     |
| at least        | Discontinue treatment  at least  18 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 18 days  prior to  slaughter.                                                                                              |
| before          | per pound of body weight, approximately 8 hours before  farrowing or immediately after completion of farrowing.                                           |
| after           | weight, approximately 8 hours before farrowing or immediately after  completion of farrowing.                                                             |
| more than       | Do not inject  more than  5 milliliters per site.                                                                                                         |
| more than       | Do not use for  more than  4 consecutive days.                                                                                                            |
| at least        | Discontinue treatment  at least  26 days before slaughter.                                                                                                |
| before          | Discontinue treatment at least 26 days  before  slaughter.                                                                                                |
| not to exceed   | 48 hours following remission of disease symptoms, however, not to exceed  a total of 4 consecutive days.                                                  |
| within          | If no improvement is noted  within  24 hours, consult a veterinarian.                                                                                     |
| more than       | When injecting the drug intramuscularly, do not inject  more than  10 milliliters per site in adult cattle.                                               |
| more than       | For very small calves do not use  more than  2 milliliters per injection site.                                                                            |
| at least        | Discontinue treatment  at least  19 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 19 days  prior to  slaughter.                                                                                              |
| within          | When administered intramuscularly  within 30 days of slaughter, muscle discoloration may necessitate                                                      |
| before          | per pound of body weight approximately 8 hours before  farrowing or immediately after farrowing.                                                          |
| after           | weight approximately 8 hours before farrowing or immediately after  farrowing.                                                                            |
| no more than    | In light turkey breeds,  no more than 25 milligrams per pound of body weight is                                                                           |
| exceed          | beyond the remission of disease symptoms, but not exceed  a total of 4 consecutive days.                                                                  |
| within          | If no improvement is noted  within 24 to 48 hours, diagnosis and therapy should                                                                           |
| more than       | injecting intramuscularly in adult livestock, do not inject more than  10 milliliters at any one site.                                                    |
| exceeds         | administration is recommended in cattle when daily dosage exceeds  50 milliliters.                                                                        |
| at least        | (vi) Treatment must be discontinued  at least 5 days prior to slaughter for chickens and                                                                  |
| prior to        | Treatment must be discontinued at least 5 days prior to slaughter for chickens and turkeys and at least                                                   |
| at least        | (vi) Treatment must be discontinued  at least 5 days prior to slaughter for chickens and                                                                  |
| prior to        | Treatment must be discontinued at least 5 days prior to slaughter for chickens and turkeys and at least                                                   |
| within          | When administered intramuscularly to animals  within 30 days of slaughter, muscle discoloration may necessitate                                           |
| not to exceed   | 48 hours beyond remission of disease symptoms, but not to exceed  a total of 4 consecutive days.                                                          |
| within          | Consult your veterinarian if no improvement is noted  within  48 hours.                                                                                   |
| more than       | Do not inject  more than 10 milliliters per site in adult cattle, reducing                                                                                |
| highest         | Exceeding the  highest recommended dose of 5 milligrams per pound of                                                                                      |
| more than       | per pound of body weight per day, administering more than the recommended number of treatments, and/or exceeding 10                                       |
| at least        | Discontinue treatment  at least  15 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 15 days  prior to  slaughter.                                                                                              |
| before          | of body weight, administered once, approximately 8 hours before  farrowing or immediately after completion of farrowing.                                  |
| after           | once, approximately 8 hours before farrowing or immediately after  completion of farrowing.                                                               |
| more than       | Do not inject  more than 5 milliliters per site in adult swine, reducing                                                                                  |
| at least        | Discontinue treatment  at least  22 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 22 days  prior to  slaughter.                                                                                              |
| not to exceed   | to 48 hours following remission of disease symptoms, not to exceed  a total of 4 consecutive days.                                                        |
| within          | If no improvement is noted  within  48 hours, consult a veterinarian.                                                                                     |
| more than       | Do not inject  more than 10 milliliters per injection site intramuscularly in adult                                                                       |
| no more than    | milliliters per injection site intramuscularly in adult cattle; no more than 1 milliliter per site in calves weighing 100                                 |
| after           | Do not slaughter cattle for 13 days  after  intramuscular or intravenous treatment, or 2 days                                                             |
| after           | Do not slaughter cattle for 13 days  after  intramuscular or intravenous treatment, or 2 days                                                             |
| highest         | Exceeding the  highest recommended dosage or duration of treatment (not more                                                                              |
| more than       | highest recommended dosage or duration of treatment (not more than 4 consecutive days) may result in residues beyond                                      |
| before          | per pound of body weight, approximately 8 hours before  farrowing or immediately after completion of farrowing.                                           |
| after           | weight, approximately 8 hours before farrowing or immediately after  completion of farrowing.                                                             |
| within          | If no improvement is noted  within  24 hours, consult a veterinarian.                                                                                     |
| more than       | Do not inject  more than  5 milliliters per site.                                                                                                         |
| at least        | Discontinue treatment  at least  20 days prior to slaughter.                                                                                              |
| prior to        | Discontinue treatment at least 20 days  prior to  slaughter.                                                                                              |
| not to exceed   | to 48 hours following remission of disease symptoms, not to exceed  a total of 4 consecutive days.                                                        |
| within          | If no improvement is noted  within 24 to 48 hours, consult a veterinarian for                                                                             |
| more than       | When injecting the drug intramuscularly, do no inject  more than  10 milliliters per site in adult cattle.                                                |
| more than       | weighing 100 pounds or less, do no inject more than  2 milliliters intramuscularly per site.                                                              |
| at least        | Discontinue treatment  at least  22 days before slaughter.                                                                                                |
| before          | Discontinue treatment at least 22 days  before  slaughter.                                                                                                |
| not to exceed   | to 48 hours following remission of disease symptoms, not to exceed  a total of 4 consecutive days.                                                        |
| within          | If no improvement is noted  within 24 to 48 hours, consult a veterinarian for                                                                             |
| more than       | In adult livestock, do not inject  more than  10 milliliters at any one site.                                                                             |
| at least        | Discontinue treatment  at least  18 days before slaughter.                                                                                                |
| before          | Discontinue treatment at least 18 days  before  slaughter.                                                                                                |
| not to exceed   | 48 hours following remission of disease symptoms, but not to exceed  a total of 4 consecutive days.                                                       |
| within          | If no improvement occurs  within  24 to 48 hours, reevaluate diagnosis and therapy.                                                                       |
| at least        | Discontinue use  at least  19 days prior to slaughter.                                                                                                    |
| prior to        | Discontinue use at least 19 days  prior to  slaughter.                                                                                                    |
| at least        | Therapy should be continued for  at least  24 hours after all symptoms have subsided.                                                                     |
| after           | should be continued for at least 24 hours after  all symptoms have subsided.                                                                              |
| at least        | Discontinue treatment  at least  21 days prior to slaughter of cattle.                                                                                    |
| prior to        | Discontinue treatment at least 21 days  prior to  slaughter of cattle.                                                                                    |
| prior to        | first dose (syringe) by subcutaneous injection 7 days prior to  the cow's or heifer's anticipated calving date.                                           |
| within          | If necessary, the first dose may be administered  within a range of 4 to 10 days prior                                                                    |
| prior to        | within a range of 4 to 10 days prior to  the anticipated calving date to accommodate management schedules.                                                |
| within          | Administer the second dose (syringe) by subcutaneous injection  within  24 hours after calving.                                                           |
| after           | dose (syringe) by subcutaneous injection within 24 hours after  calving.                                                                                  |
| within          | Not for use in beef cattle  within  30 days of slaughter.                                                                                                 |
| within          | Not for use  within  30 days of slaughter.                                                                                                                |
| at least        | Continue treatment  at least  48 hours after symptoms disappear.                                                                                          |
| after           | Continue treatment at least 48 hours  after  symptoms disappear.                                                                                          |
| at least        | 000859, 054771, 055529, and 061623: Continue treatment  at least  48 hours after symptoms disappear.                                                      |
| after           | and 061623: Continue treatment at least 48 hours after  symptoms disappear.                                                                               |
| at least        | (B) For No. 055529: Continue treatment  at least 1 day after symptoms disappear (usually 2 or                                                             |
| after           | No. 055529: Continue treatment at least 1 day after  symptoms disappear (usually 2 or 3 days).                                                            |
| after           | been taken during treatment and for 48 hours after the last treatment must not be used for                                                                |
| exceed          | 054771 and 061623: Do not  exceed 7 days of treatment in nonlactating dairy and                                                                           |
| before          | Discontinue treatment for the following number of days  before slaughter: Nonruminating cattle (calves)&#8212;7; all other cattle&#8212;4; sheep&#8212;8; |
| at least        | 000859 and 055529: Continue treatment  at least 1 day after symptoms disappear (usually 2 or                                                              |
| after           | and 055529: Continue treatment at least 1 day after  symptoms disappear (usually 2 or 3 days).                                                            |
| after           | recommended by intramuscular injection 10 to 15 minutes after  the initial dose at the same level.                                                        |
| not to exceed   | of body weight daily in three divided doses, not to exceed  800 mg daily regardless of weight.                                                            |
| not to exceed   | of body weight daily in three divided doses, not to exceed  4 g daily.                                                                                    |
| more than       | Limit intravenous administration to not  more than  5 successive days.                                                                                    |
| maximum of      | twice weekly for up to 4 weeks ( maximum of  8 injections).                                                                                               |
| after           | Administer as soon as possible  after  exposure to the poison.                                                                                            |
| before          | atropine per pound of body weight administered intramuscularly. before                                                                                    |
| at least        | mild degree of atropinization should be maintained for at least  48 hours.                                                                                |
| after           | dose of sterile pralidoxime chloride may be given after 1 hour if muscle weakness has not been                                                            |
| maximum of      | lb, 0.2 mL/5 lb body weight to a maximum of  3 mL.                                                                                                        |
| maximum         | 0.4 mL; 11 lb and over, 0.6 mL maximum .                                                                                                                  |
| after           | The dose may be repeated when necessary  after  7 days for two or three doses.                                                                            |
| least           | For use in suckling beef calves (at  least 45 days of age) up to 400 pounds                                                                               |
| prior to        | adjunctive therapy for tetanus, and as an antiemetic prior to  worming; or to prevent motion sickness in dogs.                                            |
| maximum of      | (kg)) by subcutaneous injection, once daily, for a maximum of  3 days.                                                                                    |
| at least        | or as the oral tablet in dogs weighing at least  5.5 pounds (2.5 kg) and                                                                                  |
| at least        | or as the oral tablet in dogs weighing at least  5.5 pounds (2.5 kg) and                                                                                  |
| maximum of      | at least 4 months of age, for a maximum of 3 total doses over 3 days, not to                                                                              |
| not to exceed   | maximum of 3 total doses over 3 days, not to exceed  1 dose per day.                                                                                      |
| at least        | inflammation associated with soft tissue surgery in dogs at least 4 months of age for a maximum of                                                        |
| maximum of      | at least 4 months of age for a maximum of  3 days.                                                                                                        |
| maximum of      | mg/kg) by subcutaneous injection, once daily, for a maximum of  3 days.                                                                                   |
| at least        | with orthopedic surgery, ovariohysterectomy, and castration in cats at least 4 months of age for a maximum of                                             |
| maximum of      | at least 4 months of age for a maximum of  3 days.                                                                                                        |
| prior to        | adult horses; and for use as a preanesthetic prior to  the induction of general anesthesia in adult horses.                                               |
| minimum         | 1 mL/20 lbs of body weight with a minimum dosage of 1/4 mL and a maximum dosage                                                                           |
| maximum         | a minimum dosage of 1/4 mL and a maximum  dosage of 5 mL.                                                                                                 |
| minimum         | per 40 lbs of body weight with a minimum dosage of 1/4 mL which is repeated every                                                                         |
| minimum         | age or older: 1 milliliter per 40 pounds, minimum  1 milliliter.                                                                                          |
| minimum         | Weanling pigs: 1 milliliter per 40 pounds,  minimum  1 milliliter.                                                                                        |
| before          | Calves: Discontinue use 30 days  before  treated calves are slaughtered for human consumption.                                                            |
| before          | ewes, sows, or pigs: Discontinue use 14 days before treated lambs, ewes, sows, or pigs are slaughtered                                                    |
| before          | the middle third of gestation, and 30 days before  calving.                                                                                               |
| before          | Discontinue use 30 days  before  treated cattle are slaughtered for human consumption.                                                                    |
| before          | Discontinue use 14 days  before  treated animals are slaughtered for human consumption.                                                                   |
| after           | 9th or 10th week (57 to 70 days) after  calving and continue until the end of lactation.                                                                  |
| within          | Avoid injections  within 2 weeks of expected slaughter to minimize injection                                                                              |
| within          | Do not slaughter  within  11 days of last treatment.                                                                                                      |
| more than       | the gluteal region at weekly intervals, for not more than  4 weeks.                                                                                       |
| after           | for food during treatment or for 5 days after  the last treatment.                                                                                        |
| after           | during treatment and for 60 hours (5 milkings) after the latest treatment must not be used for                                                            |
| within          | Do not administer  within  5 days of slaughter.                                                                                                           |
| more than       | weight per day by intravenous injection for not more than 4 days; or first treatment may be followed                                                      |
| within          | Do not treat  within  16 days of slaughter.                                                                                                               |
| after           | during treatment and for 72 hours (6 milkings) after the latest treatment must not be used for                                                            |
| exceed          | Treatment should not  exceed  a total of 5 consecutive days.                                                                                              |
| prior to        | Withdraw medication from cattle 10 days  prior to  slaughter.                                                                                             |
| within          | use in laying hens; do not treat chickens within  5 days of slaughter; do not treat turkeys                                                               |
| within          | use in laying hens; do not treat chickens within  5 days of slaughter; do not treat turkeys                                                               |
| before          | sedation be administered to the horse 30 minutes before  the drug is administered.                                                                        |
| at least        | When preanesthetic medication is used, wait  at least an hour before administering thiopental and sodium pentobarbital                                    |
| before          | medication is used, wait at least an hour before administering thiopental and sodium pentobarbital for injection, and                                     |
| within          | intended for human consumption must not be slaughtered within  21 days from the last treatment.                                                           |
| less than       | Supplemental doses when required should be  less than the initial dose and the total dose given                                                           |
| exceed          | dose and the total dose given should not exceed  12 mg/lb of body weight.                                                                                 |
| maximum         | The  maximum total safe dose is 13.6 mg/lb of body                                                                                                        |
| less than       | doses should be given in increments that are less than the initial dose, and the total dose given                                                         |
| exceed          | given (initial dose plus supplemental doses) should not exceed the maximum allowable safe dose of 32.7 mg/lb                                              |
| maximum         | dose plus supplemental doses) should not exceed the maximum allowable safe dose of 32.7 mg/lb of body                                                     |
| within          | Do not slaughter  within  42 days of last treatment.                                                                                                      |
| within          | Do not slaughter  within  28 days of last treatment.                                                                                                      |
| prior to        | Use 126 days  prior to  slaughter; should be reimplanted once after 63 days.                                                                              |
| after           | days prior to slaughter; should be reimplanted once after  63 days.                                                                                       |
| prior to        | Use last 63 days  prior to  slaughter.                                                                                                                    |
| after           | improved feed efficiency during 70 to 200 days after  implantation.                                                                                       |
| after           | improved feed efficiency for up to 200 days after  implantation.                                                                                          |
| exceed          | any one site, the dose injected should not exceed  0.6 mg.                                                                                                |
| exceed          | When treating animals with multiple lesions, do not  exceed  a total dose of 6 mg.                                                                        |
| after           | 3 or 4 days, repeat dosage if indicated. after                                                                                                            |
| not to exceed   | inadequate or too transient, dosage may be increased, not to exceed  3 mg.                                                                                |
| after           | 3 or 4 days, repeat dosage if indicated. after                                                                                                            |
| not to exceed   | inadequate or too transient, dosage may be increased, not to exceed  18 mg.                                                                               |
| maximum         | 100 pounds of body weight daily to a maximum  dose of 100 mg.                                                                                             |
| after           | during treatment and for 24 hours (two milkings) after the last treatment must not be used for                                                            |
| within          | intended for human consumption must not be slaughtered within  18 days from the last treatment.                                                           |
| within          | intended for human consumption must not be slaughtered within  22 days from the last treatment.                                                           |
| within          | intended for human consumption must not be slaughtered within  5 days from the last treatment.                                                            |
| more than       | weight by intramuscular injection once daily for not more than  5 consecutive days.                                                                       |
| after           | Continue treatment 24 hours  after  symptoms disappear.                                                                                                   |
| more than       | Do not inject  more than  10 mL per site.                                                                                                                 |
| less than       | Use a 50-mg/mL solution for calves weighing  less than  200 pounds.                                                                                       |
| within          | intended for human consumption must not be slaughtered within 21 days of the last use of this                                                             |
| more than       | weight by intramuscular injection twice daily for not more than  3 consecutive days.                                                                      |
| after           | Continue treatment 24 hours  after  symptoms disappear.                                                                                                   |
| after           | treatment for swine dysentery, the animal should there after receive feed containing 40 to 100 grams of                                                   |
| more than       | Do not inject  more than  5 mL per site.                                                                                                                  |
| less than       | tylosin 50-mg/mL injection be used in pigs weighing less than  25 lbs.                                                                                    |
| within          | intended for human consumption must not be slaughtered within 14 days of the last use of this                                                             |
| less than       | Do not use in Cervidae  less than  15 days before or during the hunting season.                                                                           |
| before          | not use in Cervidae less than 15 days before  or during the hunting season.                                                                               |
| before          | Do not use for 30 days  before  or during hunting season.                                                                                                 |
| before          | Do not use  before 1 month of age or after weaning in                                                                                                     |
| after           | not use before 1 month of age or after  weaning in heifers intended for reproduction.                                                                     |
| within          | Do not implant animals  within  40 days of slaughter.                                                                                                     |


## Duration

| Duration    | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 60.0 second | Administer by intravenous injection over approximately 60 seconds or until clinical signs show the onset of anesthesia, 2.2 to 9.7 mg/kilogram (kg) for cats that did not receive a preanesthetic or 1.0 to 10.8 mg/kg for cats that received a preanesthetic.                                                                                                                                                                                                                                                                                                               |
| 8.0 minute  | Administer an intravenous bolus containing 1.1 to 1.3 mg/kg to provide an additional 7 to 8 minutes of anesthesia in preanesthetized cats; a dose containing 1.4 to 1.5 mg/kg provides an additional 3 to 5 minutes anesthesia in unpreanesthetized cats.                                                                                                                                                                                                                                                                                                                    |
| 5.0 minute  | Administer an intravenous bolus containing 1.1 to 1.3 mg/kg to provide an additional 7 to 8 minutes of anesthesia in preanesthetized cats; a dose containing 1.4 to 1.5 mg/kg provides an additional 3 to 5 minutes anesthesia in unpreanesthetized cats.                                                                                                                                                                                                                                                                                                                    |
| 60.0 second | Administer by intravenous injection over approximately 60 seconds or until clinical signs show the onset of anesthesia, 1.5 to 4.5 mg/kg for dogs that did not receive a preanesthetic or 0.2 to 3.5 mg/kg for dogs that received a preanesthetic.                                                                                                                                                                                                                                                                                                                           |
| 8.0 minute  | Administer an intravenous bolus containing 1.2 to 1.4 mg/kg to provide an additional 6 to 8 minutes of anesthesia in preanesthetized dogs; a dose of 1.5 to 2.2 mg/kg provides an additional 6 to 8 minutes of anesthesia in unpreanesthetized dogs.                                                                                                                                                                                                                                                                                                                         |
| 8.0 minute  | Administer an intravenous bolus containing 1.2 to 1.4 mg/kg to provide an additional 6 to 8 minutes of anesthesia in preanesthetized dogs; a dose of 1.5 to 2.2 mg/kg provides an additional 6 to 8 minutes of anesthesia in unpreanesthetized dogs.                                                                                                                                                                                                                                                                                                                         |
| 12.0 hour   | Administer by subcutaneous or intramuscular injection every 8 to 12 hours as follows: For animals weighing up to 10 pounds (lbs): 0.1 mg; For animals weighing 11 to 20 lbs: 0.2 mg; For animals weighing 21 to 50 lbs: 0.3 mg; For animals weighing 51 to 100 lbs: 0.4 mg; For animals weighing over 100 lbs: 0.5 mg.                                                                                                                                                                                                                                                       |
| 12.0 hour   | 1 to 2 mg per pound of body weight, repeated every 12 hours as indicated, by intramuscular or intravenous injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 12.0 hour   | Administer 0.25 mg per pound of body weight, repeated every 12 hours as indicated, by intramuscular or intravenous injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 day    | Administer 7 mg by intralesional injection every other day for five treatments beginning about 30 days after initial injury.                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 5.0 day     | Administer 5 mg per pound of body weight daily for up to 5 days by intramuscular or subcutaneous injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 5.0 day     | Administer 3 to 5 mg per pound of body weight daily for up to 5 days by intramuscular or subcutaneous injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 25.0 day    | Treated animals must not be slaughtered for food during treatment and for 25 days after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 96.0 hour   | Milk from treated cows must not be used for human consumption during treatment or for 96 hours (8 milkings) after last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 3.0 day     | For enteritis: 3 mg per pound of body weight, intramuscularly, once or twice daily, for up to 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 3.0 day     | For pneumonia: 3 mg per pound of body weight, intramuscularly, twice daily, for up to 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 9.0 day     | Treated animals must not be slaughtered for food use during treatment or for 9 days after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 3.0 day     | 3 mg per pound of body weight by intramuscular injection, once or twice daily, for up to 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 15.0 day    | Treated animals must not be slaughtered for food use during treatment or for 15 days after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 5.0 day     | Usual treatment is 3 to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 4.0 day     | (B) 3 to 5 mg of ampicillin per pound of body weight, once a day for up to 4 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 5.0 day     | Usual treatment is 3 to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 7.0 day     | Do not treat cattle for more than 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 48.0 hour   | Milk from treated cows must not be used for food during treatment and for 48 hours (4 milkings) after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 144.0 hour  | Cattle must not be slaughtered for food during treatment and for 144 hours (6 days) after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 6.0 day     | Cattle must not be slaughtered for food during treatment and for 144 hours (6 days) after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 2.0 day     | Administer 0.1 milliliter (mL) per pound of body weight (1.0 mL for every 10 pounds) by intravenous injection twice a day for 2 days.                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 3.0 week    | Dosage may be repeated every 3 weeks or when symptoms recur, not to exceed a total of four injections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 week    | Dosage may be repeated every 3 weeks or when symptoms recur, not to exceed a total of 4 injections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.0 week    | Treatment may be repeated at 3-week intervals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 3.0 day     | Administer 0.24 mg per kilogram (0.11 mg per pound) by subcutaneous injection once daily, for up to 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 1.0 hour    | Administer the first dose approximately 1 hour prior to surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.0 month   | In problem cases, retreatment for whipworms may be necessary in approximately 3 months.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 21.0 day    | For hookworms, a second injection should be given 21 days after the initial treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 12.0 hour   | Administer 0.025 mg per pound of body weight by subcutaneous injection at intervals of 6 to 12 hours, as required.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 7.0 day     | Treatment should not normally be required for longer than 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 2.0 day     | Do not treat for more than 2 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 4.0 hour    | Dose may be repeated within 3 to 4 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 48.0 hour   | Treatment should not exceed 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 30.0 day    | Do not use 30 days before or during hunting season.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 2.0 hour    | For the control of postoperative pain, administer approximately 2 hours before the procedure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 14.0 day    | Following label use as a single treatment, a 14-day pre-slaughter withdrawal period is required.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 72.0 hour   | (B) Two-dose regimen: 6.6 mg ceftiofur equivalents per kg of body weight given as two injections in the base of the ear approximately 72 hours apart.                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 10.0 day    | (B) Two-dose regimen: For the treatment of acute metritis (0-to 10-days postpartum) associated with bacterial organisms susceptible to ceftiofur in lactating dairy cattle.                                                                                                                                                                                                                                                                                                                                                                                                  |
| 13.0 day    | Following label use as either a single-dose or 2-dose regimen, a 13-day pre-slaughter withdrawal period is required after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 4.0 day     | Two intramuscular injections, 4 days apart, at a dose of 3.0 mg/lb (6.6 mg/kg) body weight.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 24.0 hour   | Treatment should be repeated at 24-hour intervals for a total of 3 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 4.0 day     | Treated swine must not be slaughtered for 4 days following the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 24.0 hour   | Administer by subcutaneous or intramuscular injection as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|             |             (A) For bovine respiratory disease and acute bovine interdigital necrobacillosis: 1.1 to 2.2 mg/kg of body weight at 24-hour intervals for 3 to 5 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                              |
| 48.0 hour   | (B) For bovine respiratory disease: 2.2 mg/kg of body weight administered twice at a 48 hour interval.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 24.0 hour   | (C) For acute metritis: 2.2 mg/kg of body weight at 24-hour intervals for 5 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 14.0 day    | For treatment of bovine respiratory disease (BRD, shipping fever, pneumonia) associated with Mannheimia haemolytica, P. multocida, and Histophilus somni; acute bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus; and acute metritis (0 to 14 days post-partum) associated with bacteria susceptible to ceftiofur.                                                                                                                                                                   |
| 4.0 day     | Treated cattle must not be slaughtered for 4 days following the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 4.0 day     | Treated pigs must not be slaughtered for 4 days following the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 3.0 day     | 0.5 to 1.0 mg/lb body weight by intramuscular or subcutaneous injection for 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.0 day     | Treated cattle must not be slaughtered for 4 days following the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 3.0 day     | 0.5 to 1.0 mg/lb body weight by intramuscular injection for 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.0 day     | 0.5 to 1.0 mg/lb body weight by intramuscular injection for 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 24.0 hour   | Treatment should be repeated every 24 hours, continued for 48 hours after clinical signs have disappeared, and should not exceed 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 48.0 hour   | Treatment should be repeated every 24 hours, continued for 48 hours after clinical signs have disappeared, and should not exceed 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 10.0 day    | Treatment should be repeated every 24 hours, continued for 48 hours after clinical signs have disappeared, and should not exceed 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 24.0 hour   | Treatment should be repeated at 24-hour intervals for 5 to 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | Treatment should be repeated at 24-hour intervals for 5 to 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 6.0 hour    | 5 to 15 milligrams per pound of body weight, intramuscularly or intravenously, every 6 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 6.0 hour    | In severe infections, use 4 to 6 hour treatment intervals the first day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 1 day       | In severe infections, use 4 to 6 hour treatment intervals the first day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5.0 day     | If no response is obtained in 3 to 5 days, discontinue use and reevaluate diagnosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1.0 week    | (c) Conditions of use in cattle&#8212;(1) Amount and indications for use&#8212;(i) Administer 375 &#181;g by intramuscular injection to induce abortion in pregnant feedlot heifers from 1 week after mating until 41/2 months of gestation.                                                                                                                                                                                                                                                                                                                                 |
| 1.0 week    | (ii) Administer 500 &#181;g by intramuscular injection for terminating unwanted pregnancies from mismatings from 1 week after mating until 5 months after conception; for treating unobserved (nondetected) estrus, mummified fetus, and luteal cysts; and for the treatment of pyometra.                                                                                                                                                                                                                                                                                    |
| 5.0 month   | (ii) Administer 500 &#181;g by intramuscular injection for terminating unwanted pregnancies from mismatings from 1 week after mating until 5 months after conception; for treating unobserved (nondetected) estrus, mummified fetus, and luteal cysts; and for the treatment of pyometra.                                                                                                                                                                                                                                                                                    |
| 11.0 day    | (iii) Administer 500 &#181;g by intramuscular injection as a single injection regimen or double injection regimen with a second injection 11 days after the first, for scheduling estrus and ovulation to control the time at which cycling cows or heifers can be bred.                                                                                                                                                                                                                                                                                                     |
| 3.0 day     | (1) 1- to 3-day-old chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 3.0 day     | For subcutaneous injection in the neck of 1- to 3-day-old chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.0 month   | For subcutaneous use only; repeat dose in 3 months in young calves, in 6 months in cattle; discontinue use 30 days before treated animals are slaughtered for food use; Federal law restricts this drug to use by or on the order of a licensed veterinarian.                                                                                                                                                                                                                                                                                                                |
| 6.0 month   | For subcutaneous use only; repeat dose in 3 months in young calves, in 6 months in cattle; discontinue use 30 days before treated animals are slaughtered for food use; Federal law restricts this drug to use by or on the order of a licensed veterinarian.                                                                                                                                                                                                                                                                                                                |
| 30.0 day    | For subcutaneous use only; repeat dose in 3 months in young calves, in 6 months in cattle; discontinue use 30 days before treated animals are slaughtered for food use; Federal law restricts this drug to use by or on the order of a licensed veterinarian.                                                                                                                                                                                                                                                                                                                |
| 48.0 hour   | (i) 6 mg per kilogram (/kg) of body weight, repeated in 48 hours, for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica and Pasteurella multocida; or                                                                                                                                                                                                                                                                                                                                                                                 |
| 4.0 day     | Animals intended for human consumption should not be slaughtered within 4 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | For inducing ovulation within 48 hours in estrous mares with an ovarian follicle greater than 30 mL in diameter.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 48.0 hour   | For inducing ovulation within 48 hours in cyclic estrous mares with an ovarian follicle between 30 and 40 mL in diameter.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 25.0 day    | Initial dose of 1 milligram per pound (0.45 kilogram) of body weight every 25 days, intramuscularly.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 30.0 day    | Usual dose is 0.75 to 1.0 milligram per pound of body weight every 21 to 30 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 5.0 day     | Administer 0.25 to 1 mg by intravenous injection, repeated for 3 to 5 days or until a response is noted.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5.0 day     | Administer by intravenous injection as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|             |             (A) Dogs: 0.25 to 1 mg; may be repeated for 3 to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 12.0 hour   | Administer 5 milligrams per pound of body weight by deep intramuscular injection every 12 hours, for 3 to 5 days or until the urine is free of leptospira for at least 72 hours as measured by darkfield microscopic examination.                                                                                                                                                                                                                                                                                                                                            |
| 5.0 day     | Administer 5 milligrams per pound of body weight by deep intramuscular injection every 12 hours, for 3 to 5 days or until the urine is free of leptospira for at least 72 hours as measured by darkfield microscopic examination.                                                                                                                                                                                                                                                                                                                                            |
| 72.0 hour   | Administer 5 milligrams per pound of body weight by deep intramuscular injection every 12 hours, for 3 to 5 days or until the urine is free of leptospira for at least 72 hours as measured by darkfield microscopic examination.                                                                                                                                                                                                                                                                                                                                            |
| 30.0 day    | Discontinue use 30 days before slaughter for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 5.0 day     | As a luteolytic agent; effective only in those cattle having a corpus luteum, i.e., those which ovulated at least 5 days prior to treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.0 day     | For parturition induction in swine when injected within 3 days of normal predicted farrowing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 12.0 day    | 25 mg as an intramuscular injection either once or twice at a 10- to 12-day interval.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 100.0 day   | 25 mg as a single intramuscular injection during the first 100 days of gestation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 30.0 day    | Do not use 30 days before, or during, the hunting season in free-ranging wild animals that might be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | To control infections and to protect from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after treatment.                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | To control infections and to protect from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after treatment.                                                                                                                                                                                                                                                                                                                        |
| 28.0 day    | To control infections and to protect from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after treatment.                                                                                                                                                                                                                                                                                                                        |
| 35.0 day    | Do not slaughter cattle within 35 days of treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 20.0 month  | Not for use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 24.0 day    | Do not slaughter swine within 24 days of treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 20.0 minute | Dosage may be repeated in 15 to 20 minutes if necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 12.0 hour   | Doses may be repeated at 8 to 12 hours, if necessary, to produce desired effect.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.0 minute | (ii) For general anesthesia, administer as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |             (A) Administer 1 mL per 40 lbs of body weight by intramuscular injection in conjunction with atropine sulfate administered at the rate of 0.02 mg per pound of body weight and followed in 10 minutes by an intravenous administration of sodium pentobarbital at the rate of 3 mg per pound of body weight; or                                                                                                                                                                                                                                                  |
|             |             (B) Administer 1 mL per 25 to 60 lbs of body weight by intravenous injection in conjunction with atropine sulfate administered at the rate of 0.02 mg per pound of body weight and followed within 15 seconds by an intravenous administration of sodium pentobarbital at the rate of 3 mg per pound of body weight.                                                                                                                                                                                                                                             |
| 15.0 second | (ii) For general anesthesia, administer as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |             (A) Administer 1 mL per 40 lbs of body weight by intramuscular injection in conjunction with atropine sulfate administered at the rate of 0.02 mg per pound of body weight and followed in 10 minutes by an intravenous administration of sodium pentobarbital at the rate of 3 mg per pound of body weight; or                                                                                                                                                                                                                                                  |
|             |             (B) Administer 1 mL per 25 to 60 lbs of body weight by intravenous injection in conjunction with atropine sulfate administered at the rate of 0.02 mg per pound of body weight and followed within 15 seconds by an intravenous administration of sodium pentobarbital at the rate of 3 mg per pound of body weight.                                                                                                                                                                                                                                             |
| 3.0 day     | 2.5 mg per kilogram (/kg) of body weight (1.13 mg per pound) as a single, intramuscular, initial dose followed by use of tablets twice daily for 2 to 3 days beyond cessation of clinical signs to a maximum of 10 days.                                                                                                                                                                                                                                                                                                                                                     |
| 10.0 day    | 2.5 mg per kilogram (/kg) of body weight (1.13 mg per pound) as a single, intramuscular, initial dose followed by use of tablets twice daily for 2 to 3 days beyond cessation of clinical signs to a maximum of 10 days.                                                                                                                                                                                                                                                                                                                                                     |
| 24.0 hour   | Treatment should be repeated at 24-hour intervals for 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 3.0 day     | Treatment should be repeated at 24-hour intervals for 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 28.0 day    | Animals intended for human consumption must not be slaughtered within 28 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 20.0 month  | This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 5.0 day     | Animals intended for human consumption must not be slaughtered within 5 days of receiving a single-injection dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 100.0 day   | Prevents reinfection with C. oncophora, C. punctata, and T. axei for 100 days following treatment; H. placei, O. radiatum,                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|             |               O. lyrata, and O. ostertagi for 120 days following treatment; and B. phlebotomum and D. viviparus for 150 days following treatment.                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 120.0 day   | Prevents reinfection with C. oncophora, C. punctata, and T. axei for 100 days following treatment; H. placei, O. radiatum,                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|             |               O. lyrata, and O. ostertagi for 120 days following treatment; and B. phlebotomum and D. viviparus for 150 days following treatment.                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 150.0 day   | Prevents reinfection with C. oncophora, C. punctata, and T. axei for 100 days following treatment; H. placei, O. radiatum,                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|             |               O. lyrata, and O. ostertagi for 120 days following treatment; and B. phlebotomum and D. viviparus for 150 days following treatment.                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 48.0 day    | Animals intended for human consumption must not be slaughtered within 48 days of the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 20.0 month  | This drug product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 5.0 day     | 3 to 5 mg per pound (/lb) body weight, intramuscularly, two to three times daily, for up to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 5.0 day     | 3 to 5 mg/lb body weight, intramuscularly, two to three times daily, for up to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 5.0 day     | 4 mg/lb body weight by deep intramuscular injection once daily for up to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 20.0 month  | Do not use in female dairy cattle over 20 months of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 6.0 day     | Do not slaughter treated animals within 6 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | To avoid excess trim, do not slaughter within 21 days of last injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 200.0 day   | Insert one 25.7-mg implant every 200 days; insert one 43.9-mg implant every 400 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 400.0 day   | Insert one 25.7-mg implant every 200 days; insert one 43.9-mg implant every 400 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 200.0 day   | No additional effectiveness may be expected from reimplanting in less than 200 days for the 25.7-mg implant or 400 days for the 43.9-mg implant.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 400.0 day   | No additional effectiveness may be expected from reimplanting in less than 200 days for the 25.7-mg implant or 400 days for the 43.9-mg implant.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 48.0 hour   | When inseminating without estrus detection, the entire treated group should be started at 48 hours after the last implant has been removed and should be completed within 6 hours.                                                                                                                                                                                                                                                                                                                                                                                           |
| 6.0 hour    | When inseminating without estrus detection, the entire treated group should be started at 48 hours after the last implant has been removed and should be completed within 6 hours.                                                                                                                                                                                                                                                                                                                                                                                           |
| 12.0 hour   | Where estrus detection is preferred, insemination should be approximately 12 hours after first detection of estrus.                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 25.0 day    | Those that do not conceive can be re-bred when they return to estrus approximately 17 to 25 days after implant removal.                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 24.0 hour   | If needed, the daily dose of etodolac tablets as in &#167;&#8201;520.870 of this chapter may be given 24 hours after the injection.                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 30.0 day    | Do not use 30 days before, or during, the hunting season in free-ranging wild animals that might be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 150.0 day   | (e) Conditions of use&#8212;(1) Cattle&#8212;(i) Indications for use and amount&#8212;(A) For feedlot heifers to induce abortion when pregnant 150 days or less, administer 1 mg (2 milliliter (mL)) subcutaneously.                                                                                                                                                                                                                                                                                                                                                         |
| 13.0 day    | (B) For beef or nonlactating dairy cattle for estrus synchronization, administer a single or two 1-mg (2-mL) doses subcutaneously, 11 to 13 days apart.                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 112.0 day   | For the induction of parturition in sows and gilts pregnant at least 112 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 5.0 day     | Administer 0.04 mg/pound (lb) (0.09 mg/kilogram (kg)) of body weight (BW) intravenously, once daily, for up to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 9.0 day     | If further treatment is needed, firocoxib oral paste can be administered at a dosage of 0.045 mg/lb (0.1 mg/kg) of BW for up to an additional 9 days of treatment.                                                                                                                                                                                                                                                                                                                                                                                                           |
| 44.0 day    | Animals intended for human consumption must not be slaughtered within 44 days of treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 20.0 month  | Do not use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 48.0 hour   | A second dose should be administered 48 hours later.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 28.0 day    | Animals intended for human consumption must not be slaughtered within 28 days of the last intramuscular treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 33.0 day    | Animals intended for human consumption must not be slaughtered within 33 days of subcutaneous treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 20.0 month  | This product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 38.0 day    | Animals intended for human consumption must not be slaughtered within 38 days of treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 20.0 month  | This drug product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 3.0 day     | Dosage by injection should not exceed 3 days of therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5.0 day     | 0.5 mg per pound (/lb) of body weight per day, intravenously or intramuscularly, for up to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 12.0 hour   | (2) Cattle&#8212;(i) Amounts and indications for use&#8212;(A) Administer 1.1 to 2.2 mg/kilogram (kg) (0.5 to 1.0 mg/lb) of body weight per day intravenously, as a single dose or divided into two doses administered at 12-hour intervals, for up to 3 days for control of pyrexia associated with bovine respiratory disease and endotoxemia or for control of inflammation in endotoxemia.                                                                                                                                                                               |
| 3.0 day     | (2) Cattle&#8212;(i) Amounts and indications for use&#8212;(A) Administer 1.1 to 2.2 mg/kilogram (kg) (0.5 to 1.0 mg/lb) of body weight per day intravenously, as a single dose or divided into two doses administered at 12-hour intervals, for up to 3 days for control of pyrexia associated with bovine respiratory disease and endotoxemia or for control of inflammation in endotoxemia.                                                                                                                                                                               |
| 4.0 day     | Cattle must not be slaughtered for human consumption within 4 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 36.0 hour   | Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 12.0 day    | Swine must not be slaughtered for human consumption within 12 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 3.0 day     | 12.5 units of follicle stimulating hormone twice a day for 3 days (a total of 75 units).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 12.0 hour   | Administer 2.5 mL (87.5 IU) intramuscularly, twice daily at 12-hour intervals, for 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 12.0 hour   | 500 mg/animal once daily, intramuscularly or intravenously; or 250 mg/animal twice daily at 12-hour intervals, intramuscularly or intravenously.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 48.0 hour   | Treatment not to exceed 48 hours post-parturition.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 48.0 hour   | Milk taken during treatment and for 48 hours (four milkings) after the last treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 48.0 hour   | Cattle must not be slaughtered for food within 48 hours following last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 35.0 day    | Cattle intended for human consumption must not be slaughtered within 35 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 20.0 month  | Do not use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 1 day       | Two milligrams of gentamicin per pound of body weight, twice daily on the first day, once daily thereafter, using a 50 milligram-per-milliliter solution.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 7.0 day     | If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested.                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 3.0 day     | For 1- to 3-day old turkey poults.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 9.0 week    | Injected poults must not be slaughtered for food for at least 9 weeks after treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 5.0 week    | Do not slaughter treated animals for food for at least 5 weeks after treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 3.0 day     | In piglets up to 3 days old for treatment of porcine colibacillosis caused by strains of E. coli sensitive to gentamicin.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 3.0 day     | For single intramuscular dose in pigs up to 3 days of age only.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 40.0 day    | Do not slaughter treated animals for food for at least 40 days following treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1 day       | 2 milligrams of gentamicin per pound of body weight, twice daily on the first day, then once daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.0 day     | If no improvement is seen after 3 days, treatment should be discontinued and the diagnosis reevaluated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 7.0 day     | Treatment not to exceed 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 3.0 day     | (i) Prevention of anemia due to iron deficiency: Administer 1 mL (200 mg iron) per pig by intramuscular injection on or before 3 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 8.0 day     | (iv) For use with cloprostenol injection to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows: Administer to each cow 86 &#181;g gonadorelin by intramuscular injection, followed 6 to 8 days later by 500 &#181;g cloprostenol by intramuscular injection, followed 30 to 72 hours later by 86 &#181;g gonadorelin by intramuscular injection.                                                                                                                                                                      |
| 72.0 hour   | (iv) For use with cloprostenol injection to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows: Administer to each cow 86 &#181;g gonadorelin by intramuscular injection, followed 6 to 8 days later by 500 &#181;g cloprostenol by intramuscular injection, followed 30 to 72 hours later by 86 &#181;g gonadorelin by intramuscular injection.                                                                                                                                                                      |
| 8.0 day     | (v) For use with cloprostenol injection to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows and beef cows: Administer to each cow 100 &#181;g gonadorelin by intramuscular injection, followed 6 to 8 days later by 500 &#181;g cloprostenol by intramuscular injection, followed 30 to 72 hours later by 100 &#181;g gonadorelin by intramuscular injection.                                                                                                                                                       |
| 72.0 hour   | (v) For use with cloprostenol injection to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in lactating dairy cows and beef cows: Administer to each cow 100 &#181;g gonadorelin by intramuscular injection, followed 6 to 8 days later by 500 &#181;g cloprostenol by intramuscular injection, followed 30 to 72 hours later by 100 &#181;g gonadorelin by intramuscular injection.                                                                                                                                                       |
| 8.0 day     | (vi) For use with dinoprost injection to synchronize estrous cycles to allow fixed-time artificial insemination (FTAI) in lactating dairy cows: Administer to each cow 100 to 200 &#181;g gonadorelin by intramuscular injection, followed 6 to 8 days later by 25 mg dinoprost by intramuscular injection, followed 30 to 72 hours later by 100 to 200 &#181;g gonadorelin by intramuscular injection.                                                                                                                                                                      |
| 72.0 hour   | (vi) For use with dinoprost injection to synchronize estrous cycles to allow fixed-time artificial insemination (FTAI) in lactating dairy cows: Administer to each cow 100 to 200 &#181;g gonadorelin by intramuscular injection, followed 6 to 8 days later by 25 mg dinoprost by intramuscular injection, followed 30 to 72 hours later by 100 to 200 &#181;g gonadorelin by intramuscular injection.                                                                                                                                                                      |
| 14.0 day    | Dosage may be repeated in 14 days if the animal's behavior or examination of the ovaries per rectum indicates retreatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 9.0 week    | Administer 0.4 mg (2 milliliter (mL)) by subcutaneous injection no earlier than 9 weeks of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 4.0 week    | A second subcutaneous injection of 0.4 mg (2 mL) should be administered at least 4 weeks after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 3.0 week    | Pigs should be slaughtered no earlier than 3 weeks and no later than 10 weeks after the second dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 10.0 week   | Pigs should be slaughtered no earlier than 3 weeks and no later than 10 weeks after the second dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 4.0 week    | Treatment may be repeated after 1 or more weeks but not to exceed 2 injections per week for a total of 4 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 72.0 hour   | Milk taken from dairy animals during treatment and for 72 hours (6 milkings) after the latest treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 24.0 hour   | For Babesia caballi infections, administer 2 mg of imidocarb base per kilogram of body weight by intramuscular injection in the neck region, repeating dosage once after 24 hours.                                                                                                                                                                                                                                                                                                                                                                                           |
| 72.0 hour   | For Babesia equi infections, administer 4 mg of imidocarb base per kilogram of body weight by intramuscular injection in the neck region, repeating dosage four times at 72-hour intervals.                                                                                                                                                                                                                                                                                                                                                                                  |
| 2.0 week    | Repeat the dose after 2 weeks for a total of two treatments.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 12.0 hour   | Injections should be given twice daily at approximately 12-hour intervals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 12.0 hour   | Administer an initial dose of 0.1 to 0.3 IU/pound of body weight (0.2 to 0.7 IU/kilogram) every 12 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 4.0 day     | 000859 and 042552 for use of product described in paragraph (a)(1)(i) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|             |             (i) For prevention of iron deficiency anemia, inject 100 mg (1 mL) by intramuscular injection at 2 to 4 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.0 day    | Dosage may be repeated in approximately 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 4.0 day     | (2) No. 054771 for use of product described in paragraph (a)(1)(i) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|             |             (i) For the prevention of anemia due to iron deficiency, administer an initial intramuscular injection of 100 mg at 2 to 4 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 21.0 day    | Dosage may be repeated in 14 to 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 3.0 day     | 000061 and 013744 for use of product described in paragraph (a)(1)(i) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|             |             (i) For the prevention of iron deficiency anemia, administer intramuscularly an amount of drug containing 100 to 150 mg of elemental iron to animals from 1 to 3 days of age.                                                                                                                                                                                                                                                                                                                                                                                    |
| 10.0 day    | Dosage may be repeated in 10 days to 2 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 2.0 week    | Dosage may be repeated in 10 days to 2 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 5.0 day     | 051311 and 054771 for use of product described in paragraph (a)(1)(ii) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|             |             (i) For prevention of iron deficiency anemia, administer 1 mL by intramuscular injection at 2 to 5 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 2.0 week    | Dosage may be repeated at 2 weeks of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 28.0 day    | (ii) For treatment of iron deficiency anemia, administer 1 to 2 mL by intramuscular injection at 5 to 28 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 4.0 day     | (5) No. 054771 for use of product described in paragraph (a)(1)(iii) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|             |             (i) For prevention of anemia due to iron deficiency, administer 100 mg by intramuscular or subcutaneous injection at 2 to 4 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 4.0 week    | (ii) For treatment of anemia due to iron deficiency, administer 100 mg by intramuscular or subcutaneous injection up to 4 weeks of age.                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 4.0 day     | 016592 and 058005 for use of product described in paragraph (a)(1)(iii) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |             (i) For prevention of anemia due to iron deficiency, administer 100 mg by intramuscular injection at 2 to 4 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 10.0 day    | Treatment may be repeated in 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 3.0 day     | 016592 and 042552 for use of product described in paragraph (a)(2) of this section as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|             |             (i) For prevention of anemia due to iron deficiency, intramuscularly inject 200 mg of elemental iron (1 mL) at 1 to 3 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 7.0 day     | Animals intended for human consumption should not be slaughtered within 7 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 7.0 day     | Animals intended for human consumption should not be slaughtered within 7 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 28.0 day    | For control of infections and to protect from reinfection with D. viviparus and O. radiatum for 28 days after treatment; O. ostertagi, T. axei, and C. punctata for 21 days after treatment; H. placei and C. oncophora for 14 days after treatment.                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | For control of infections and to protect from reinfection with D. viviparus and O. radiatum for 28 days after treatment; O. ostertagi, T. axei, and C. punctata for 21 days after treatment; H. placei and C. oncophora for 14 days after treatment.                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | For control of infections and to protect from reinfection with D. viviparus and O. radiatum for 28 days after treatment; O. ostertagi, T. axei, and C. punctata for 21 days after treatment; H. placei and C. oncophora for 14 days after treatment.                                                                                                                                                                                                                                                                                                                         |
| 35.0 day    | Do not treat cattle within 35 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 18.0 day    | Do not treat swine within 18 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 56.0 day    | Do not slaughter within 56 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 56.0 day    | Do not treat reindeer within 56 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 3.0 week    | Repeat in 3 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 28.0 day    | bovis); and for control of infections of D. viviparus and O. radiatum for 28 days afer treatment; O. ostertagi, T. axei, and C. punctata for 21 days after treatment; and H. placei and C. oncophora for 14 days after treatment.                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | bovis); and for control of infections of D. viviparus and O. radiatum for 28 days afer treatment; O. ostertagi, T. axei, and C. punctata for 21 days after treatment; and H. placei and C. oncophora for 14 days after treatment.                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | bovis); and for control of infections of D. viviparus and O. radiatum for 28 days afer treatment; O. ostertagi, T. axei, and C. punctata for 21 days after treatment; and H. placei and C. oncophora for 14 days after treatment.                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | For No. 050604: Do not treat cattle within 21 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 49.0 day    | 055529 and 058005: Do not treat cattle within 49 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 12.0 hour   | Administer by subcutaneous or intramuscular injection 5 mg per pound of body weight per day in equally divided doses at 12-hour intervals.                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 5.0 day     | Administer by intravenous injection 1.0 mg per pound of body weight once daily for up to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 4.0 week    | Cattle that are severely parasitized or maintained under conditions of constant helminth exposure may require re-treatment within 2 to 4 weeks after first treatment.                                                                                                                                                                                                                                                                                                                                                                                                        |
| 7.0 day     | Do not administer to cattle within 7 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 7.0 day     | 5 mg/lb body weight once daily by intramuscular injection for 3 to 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Do not treat within 48 hours of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 6.0 month   | 10 mg per kilogram (4.5 mg per pound) of body weight every 6 months, by subcutaneous injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 6.0 week    | For control of flea populations in cats 6 weeks of age and older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 12.0 week   | As a sedative and analgesic in dogs over 12 weeks of age to facilitate clinical examinations, clinical procedures, minor surgical procedures not requiring muscle relaxation, and minor dental procedures not requiring intubation.                                                                                                                                                                                                                                                                                                                                          |
| 4.0 month   | Treatment of stabilized, class 1, 2, and 3 heartworm disease (asymptomatic to mild, moderate, and severe, respectively) caused by immature (4 month-old, stage L5) to mature adult infections of Dirofilaria immitis in dogs.                                                                                                                                                                                                                                                                                                                                                |
| 1 day       | Administer 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) by intravenous or subcutaneous injection on the first day of treatment.                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 42.0 day    | bovis); lice: Linognathus vituli and Solenopotes capillatus; for protection of cattle from reinfection with D. viviparus and O. radiatum for 42 days after treatment, with H. placei for 35 days after treatment, and with O. ostertagi and T. axei for 14 days after treatment.                                                                                                                                                                                                                                                                                             |
| 35.0 day    | bovis); lice: Linognathus vituli and Solenopotes capillatus; for protection of cattle from reinfection with D. viviparus and O. radiatum for 42 days after treatment, with H. placei for 35 days after treatment, and with O. ostertagi and T. axei for 14 days after treatment.                                                                                                                                                                                                                                                                                             |
| 14.0 day    | bovis); lice: Linognathus vituli and Solenopotes capillatus; for protection of cattle from reinfection with D. viviparus and O. radiatum for 42 days after treatment, with H. placei for 35 days after treatment, and with O. ostertagi and T. axei for 14 days after treatment.                                                                                                                                                                                                                                                                                             |
| 21.0 day    | Do not slaughter cattle within 21 days of treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 20.0 month  | Because a withholding time for milk has not been established, do not use in female dairy cattle 20 months of age and older.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 1 quarter   | One-quarter of the dose should be administered intravenously and three-quarters of the dose should be administered subcutaneously.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 3 quarter   | One-quarter of the dose should be administered intravenously and three-quarters of the dose should be administered subcutaneously.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 45.0 day    | Do not use in free-ranging animals for 45 days before or during hunting season.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 8.0 hour    | Administer 5 mg per pound of body weight daily by intramuscular or intravenous injection, divided into portions administered every 6 to 8 hours for 3 to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                             |
| 5.0 day     | Administer 5 mg per pound of body weight daily by intramuscular or intravenous injection, divided into portions administered every 6 to 8 hours for 3 to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                             |
| 2.0 week    | Administer by deep intramuscular injection at a dosage level of 5 milligrams (mg) every other day for 2 weeks and twice weekly for 2 to 3 more weeks.                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 5.0 week    | Dosage may be continued beyond 5 weeks if satisfactory improvement has not been achieved.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 6.0 day     | Administer by subcutaneous injection 5 mg daily for 6 days, and thereafter, every other day for 8 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 8.0 day     | Administer by subcutaneous injection 5 mg daily for 6 days, and thereafter, every other day for 8 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 5.0 minute  | Oxytetracycline should be administered intravenously slowly over a period of at least 5 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 28.0 day    | Discontinue treatment at least 28 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 96.0 hour   | Milk taken from animals during treatment and for 96 hours after the last treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 8.0 hour    | (2) Swine&#8212;(i) Amounts and indications for use&#8212;(A) Sows: 3 mg/lb BW intramuscularly once, approximately 8 hours before farrowing or immediately after completion of farrowing, as an aid in control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by E.                                                                                                                                                                                                                                                                       |
|             |               coli.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 28.0 day    | Discontinue treatment at least 28 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Treatment should be continued 24 to 48 hours following remission of disease signs, however, not to exceed a total of four consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 5.0 minute  | Oxytetracycline should be administered intravenously slowly over a period of at least 5 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 28.0 day    | Discontinue treatment at least 28 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 8.0 hour    | (2) Swine&#8212;(i) Amounts and indications for use&#8212;(A) Sows: 3 mg/lb BW intramuscularly once, approximately 8 hours before farrowing or immediately after completion of farrowing, as an aid in control of infectious enteritis (baby pig scours, colibacillosis) in suckling pigs caused by E.                                                                                                                                                                                                                                                                       |
|             |               coli.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 48.0 hour   | Treatment should be continued 24 to 48 hours beyond remission of disease signs, however, not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 28.0 day    | Discontinue treatment at least 28 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Treatment should be continued for 24 to 48 hours following remission of disease symptoms; however, not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 20.0 day    | (iii) Discontinue treatment with the drug at least 20 days prior to slaughter of the animal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 30.0 day    | When administered to animals within 30 days of slaughter, muscle discoloration may necessitate trimming of injection site and surrounding tissues.                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 48.0 hour   | Treatment of all diseases should be instituted early and continue for 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                  |
| 48.0 hour   | Consult your veterinarian if no improvement is noted within 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 18.0 day    | Discontinue treatment at least 18 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 8.0 hour    | Sows: 3 milligrams of oxytetracycline per pound of body weight, approximately 8 hours before farrowing or immediately after completion of farrowing.                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 26.0 day    | Discontinue treatment at least 26 days before slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 48.0 hour   | Treatment should be continued 24 to 48 hours following remission of disease symptoms, however, not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 24.0 hour   | If no improvement is noted within 24 hours, consult a veterinarian.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 19.0 day    | Discontinue treatment at least 19 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 30.0 day    | When administered intramuscularly within 30 days of slaughter, muscle discoloration may necessitate trimming of the injection site and surrounding tissues.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 8.0 hour    | Administered to sows at 3 milligrams of oxytetracycline per pound of body weight approximately 8 hours before farrowing or immediately after farrowing.                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 1.0 day     | (b) Administered subcutaneously to chickens 1 day to 2 weeks of age at 6.25 milligrams of oxytetracycline per bird per day diluted with 1 part of the drug to 3 parts of sterile water; to chickens 2 to 4 weeks of age using the same diluted product at 12.5 milligrams of oxytetracycline per bird; to chickens 4 to 8 weeks of age without dilution at 25 milligrams of oxytetracycline per bird; to chickens 8 weeks of age (broilers and light pullets) at 50 milligrams of oxytetracycline per bird; to adult chickens at 100 milligrams of oxytetracycline per bird. |
| 2.0 week    | (b) Administered subcutaneously to chickens 1 day to 2 weeks of age at 6.25 milligrams of oxytetracycline per bird per day diluted with 1 part of the drug to 3 parts of sterile water; to chickens 2 to 4 weeks of age using the same diluted product at 12.5 milligrams of oxytetracycline per bird; to chickens 4 to 8 weeks of age without dilution at 25 milligrams of oxytetracycline per bird; to chickens 8 weeks of age (broilers and light pullets) at 50 milligrams of oxytetracycline per bird; to adult chickens at 100 milligrams of oxytetracycline per bird. |
| 4.0 week    | (b) Administered subcutaneously to chickens 1 day to 2 weeks of age at 6.25 milligrams of oxytetracycline per bird per day diluted with 1 part of the drug to 3 parts of sterile water; to chickens 2 to 4 weeks of age using the same diluted product at 12.5 milligrams of oxytetracycline per bird; to chickens 4 to 8 weeks of age without dilution at 25 milligrams of oxytetracycline per bird; to chickens 8 weeks of age (broilers and light pullets) at 50 milligrams of oxytetracycline per bird; to adult chickens at 100 milligrams of oxytetracycline per bird. |
| 8.0 week    | (b) Administered subcutaneously to chickens 1 day to 2 weeks of age at 6.25 milligrams of oxytetracycline per bird per day diluted with 1 part of the drug to 3 parts of sterile water; to chickens 2 to 4 weeks of age using the same diluted product at 12.5 milligrams of oxytetracycline per bird; to chickens 4 to 8 weeks of age without dilution at 25 milligrams of oxytetracycline per bird; to chickens 8 weeks of age (broilers and light pullets) at 50 milligrams of oxytetracycline per bird; to adult chickens at 100 milligrams of oxytetracycline per bird. |
| 8.0 week    | (b) Administered subcutaneously to chickens 1 day to 2 weeks of age at 6.25 milligrams of oxytetracycline per bird per day diluted with 1 part of the drug to 3 parts of sterile water; to chickens 2 to 4 weeks of age using the same diluted product at 12.5 milligrams of oxytetracycline per bird; to chickens 4 to 8 weeks of age without dilution at 25 milligrams of oxytetracycline per bird; to chickens 8 weeks of age (broilers and light pullets) at 50 milligrams of oxytetracycline per bird; to adult chickens at 100 milligrams of oxytetracycline per bird. |
| 1.0 day     | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 2.0 week    | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 4.0 week    | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 6.0 week    | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 9.0 week    | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 12.0 week   | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 12.0 week   | (c) Administered subcutaneously to turkeys 1 day to 2 weeks of age and 2 to 4 weeks of age at the same dosage as chickens; to turkeys 4 to 6 weeks of age at 50 milligrams of oxytetracycline as the undiluted product per bird; to turkeys 6 to 9 weeks of age at 100 milligrams of oxytetracycline per bird; to turkeys 9 to 12 weeks of age at 150 milligrams of oxytetracycline per bird; to turkeys 12 weeks of age and older at 200 milligrams of oxytetracycline per bird.                                                                                            |
| 7.0 day     | If refilling of the sinuses occurs, the treatment may be repeated in 5 to 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 48.0 hour   | Treatment should continue for 24 to 48 hours beyond the remission of disease symptoms, but not exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 48.0 hour   | If no improvement is noted within 24 to 48 hours, diagnosis and therapy should be reevaluated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 5.0 day     | (vi) Treatment must be discontinued at least 5 days prior to slaughter for chickens and turkeys and at least 22 days prior to slaughter for cattle and swine.                                                                                                                                                                                                                                                                                                                                                                                                                |
| 22.0 day    | (vi) Treatment must be discontinued at least 5 days prior to slaughter for chickens and turkeys and at least 22 days prior to slaughter for cattle and swine.                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 day    | When administered intramuscularly to animals within 30 days of slaughter, muscle discoloration may necessitate trimming of the injection site(s) and surrounding tissues during the dressing procedure.                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | Treatment of all diseases should be instituted early and continue for 24 to 48 hours beyond remission of disease symptoms, but not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                  |
| 48.0 hour   | Consult your veterinarian if no improvement is noted within 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 15.0 day    | Discontinue treatment at least 15 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 8.0 hour    | Sows: 3 milligrams of oxytetracycline per pound of body weight, administered once, approximately 8 hours before farrowing or immediately after completion of farrowing.                                                                                                                                                                                                                                                                                                                                                                                                      |
| 22.0 day    | Discontinue treatment at least 22 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Continue treatment 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | If no improvement is noted within 48 hours, consult a veterinarian.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 13.0 day    | Do not slaughter cattle for 13 days after intramuscular or intravenous treatment, or 2 days after subcutaneous treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 2.0 day     | Do not slaughter cattle for 13 days after intramuscular or intravenous treatment, or 2 days after subcutaneous treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 8.0 hour    | Sows: Administer once 3 milligrams of oxytetracycline per pound of body weight, approximately 8 hours before farrowing or immediately after completion of farrowing.                                                                                                                                                                                                                                                                                                                                                                                                         |
| 24.0 hour   | If no improvement is noted within 24 hours, consult a veterinarian.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 20.0 day    | Discontinue treatment at least 20 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Continue treatment 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | If no improvement is noted within 24 to 48 hours, consult a veterinarian for diagnosis and therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 22.0 day    | Discontinue treatment at least 22 days before slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 48.0 hour   | Continue treatment 24 to 48 hours following remission of disease symptoms, not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | If no improvement is noted within 24 to 48 hours, consult a veterinarian for diagnosis and therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 18.0 day    | Discontinue treatment at least 18 days before slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 48.0 hour   | Treatment should be continued 24 to 48 hours following remission of disease symptoms, but not to exceed a total of 4 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 48.0 hour   | If no improvement occurs within 24 to 48 hours, reevaluate diagnosis and therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 19.0 day    | Discontinue use at least 19 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 12.0 hour   | (2) The drug is administered intramuscularly at a recommended daily dosage to dogs at 5 milligrams per pound of body weight administered in divided doses at 6 to 12 hour intervals.                                                                                                                                                                                                                                                                                                                                                                                         |
| 24.0 hour   | Therapy should be continued for at least 24 hours after all symptoms have subsided.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 21.0 day    | Discontinue treatment at least 21 days prior to slaughter of cattle.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 20.0 month  | This drug product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 7.0 day     | Administer the first dose (syringe) by subcutaneous injection 7 days prior to the cow's or heifer's anticipated calving date.                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.0 day    | If necessary, the first dose may be administered within a range of 4 to 10 days prior to the anticipated calving date to accommodate management schedules.                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 24.0 hour   | Administer the second dose (syringe) by subcutaneous injection within 24 hours after calving.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 day    | For the reduction in the incidence of clinical mastitis in the first 30 days of lactation in periparturient dairy cows and periparturient replacement dairy heifers.                                                                                                                                                                                                                                                                                                                                                                                                         |
| 48.0 hour   | Repeat dosage in 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Repeat dosage in 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Repeat dosage in 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 30.0 day    | Not for use in beef cattle within 30 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | Repeat dosage in 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 30.0 day    | Not for use within 30 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 24.0 hour   | 10,000 units per pound body weight daily by intramuscular injection at 24-hour intervals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 48.0 hour   | Continue treatment at least 48 hours after symptoms disappear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 48.0 hour   | 000859, 054771, 055529, and 061623: Continue treatment at least 48 hours after symptoms disappear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 1.0 day     | (B) For No. 055529: Continue treatment at least 1 day after symptoms disappear (usually 2 or 3 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 3.0 day     | (B) For No. 055529: Continue treatment at least 1 day after symptoms disappear (usually 2 or 3 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 48.0 hour   | Milk that has been taken during treatment and for 48 hours after the last treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 7.0 day     | 054771 and 061623: Do not exceed 7 days of treatment in nonlactating dairy and beef cattle, sheep, and swine, or 5 days in lactating cattle.                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 5.0 day     | 054771 and 061623: Do not exceed 7 days of treatment in nonlactating dairy and beef cattle, sheep, and swine, or 5 days in lactating cattle.                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 1.0 day     | 000859 and 055529: Continue treatment at least 1 day after symptoms disappear (usually 2 or 3 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 3.0 day     | 000859 and 055529: Continue treatment at least 1 day after symptoms disappear (usually 2 or 3 days).                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 15.0 minute | In cases of severe pain, a second dose is recommended by intramuscular injection 10 to 15 minutes after the initial dose at the same level.                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 4.0 week    | Treatment may be repeated in 1 to 4 weeks, or as indicated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 5.0 week    | (ii) Amount&#8212;(A) Intra-articular use (carpal): 250 mg once a week for 5 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.0 day     | (B) Intramuscular use (carpal and hock): 500 mg every 4 days for 28 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 28.0 day    | (B) Intramuscular use (carpal and hock): 500 mg every 4 days for 28 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 4.0 week    | 2 mg per pound of body weight by intramuscular injection twice weekly for up to 4 weeks (maximum of 8 injections).                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 48.0 hour   | A mild degree of atropinization should be maintained for at least 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 1.0 hour    | Following severe poisoning, a second dose of sterile pralidoxime chloride may be given after 1 hour if muscle weakness has not been relieved.                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 7.0 day     | The dose may be repeated when necessary after 7 days for two or three doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.0 hour   | Administer intravenously in a dosage of 21/2 to 5 mg per pound of body weight, initially for shock and shock-like states, followed by equal maintenance doses at 1-, 3-, 6-, or 10-hour intervals as determined by the condition of the animal.                                                                                                                                                                                                                                                                                                                              |
| 1.0 minute  | Administer 50 to 100 mg as an initial dose by intravenous injection over a period of one-half to 1 minute, or by intramuscular injection, and may be repeated in inflammatory, allergic, or other stress conditions at intervals of 12, 24, or 48 hours, depending upon the size of the animal, the severity of the condition and the response to treatment.                                                                                                                                                                                                                 |
| 48.0 hour   | Administer 50 to 100 mg as an initial dose by intravenous injection over a period of one-half to 1 minute, or by intramuscular injection, and may be repeated in inflammatory, allergic, or other stress conditions at intervals of 12, 24, or 48 hours, depending upon the size of the animal, the severity of the condition and the response to treatment.                                                                                                                                                                                                                 |
| 10.0 hour   | Administer by intravenous injection at a range of 2.5 to 5 mg per pound of body weight as an initial dose followed by maintenance doses at 1, 3, 6, or 10 hour intervals, as determined by the condition of the animal, for treatment of shock.                                                                                                                                                                                                                                                                                                                              |
| 24.0 hour   | Dosage may be repeated in 12 to 24 hours and continued for 3 to 5 days if necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 5.0 day     | Dosage may be repeated in 12 to 24 hours and continued for 3 to 5 days if necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 48.0 hour   | Retreatment of horses in 24 to 48 hours may be necessary, depending on the general condition of the animal and the severity and duration of the disease.                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5.0 day     | Administer 0.25 to 1.0 mg per pound of body weight by intramuscular injection for 3 to 5 days or until a response is noted.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 45.0 day    | For use in suckling beef calves (at least 45 days of age) up to 400 pounds (lb) of body weight.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 6.0 hour    | (c) Conditions of use&#8212;(1) Horses&#8212;(i) Amount&#8212;(A) 0.2 to 0.5 milligrams per pounds (mg/lb) body weight intramuscularly or intravenously every 4 to 6 hours.                                                                                                                                                                                                                                                                                                                                                                                                  |
| 6.0 hour    | 1 to 2 mg/lb body weight intramuscularly or intravenously every 4 to 6 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 12.0 hour   | Dosage may be repeated every 6 to 12 hours whenever necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 12.0 hour   | Dosage may be repeated every 6 to 12 hours if necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 3.0 day     | Administer 0.91 mg per pound (2 mg/kilogram (kg)) by subcutaneous injection, once daily, for a maximum of 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 4.0 month   | After the initial subcutaneous dose, subsequent doses can be given by subcutaneous injection or as the oral tablet in dogs weighing at least 5.5 pounds (2.5 kg) and at least 4 months of age, for a maximum of 3 total doses over 3 days, not to exceed 1 dose per day.                                                                                                                                                                                                                                                                                                     |
| 3.0 day     | After the initial subcutaneous dose, subsequent doses can be given by subcutaneous injection or as the oral tablet in dogs weighing at least 5.5 pounds (2.5 kg) and at least 4 months of age, for a maximum of 3 total doses over 3 days, not to exceed 1 dose per day.                                                                                                                                                                                                                                                                                                     |
| 4.0 month   | For the control of postoperative pain and inflammation associated with soft tissue surgery in dogs at least 4 months of age for a maximum of 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 3.0 day     | For the control of postoperative pain and inflammation associated with soft tissue surgery in dogs at least 4 months of age for a maximum of 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 3.0 day     | Administer 0.91 mg per pound (2 mg/kg) by subcutaneous injection, once daily, for a maximum of 3 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 4.0 month   | For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration in cats at least 4 months of age for a maximum of 3 days.                                                                                                                                                                                                                                                                                                                                                                                      |
| 3.0 day     | For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration in cats at least 4 months of age for a maximum of 3 days.                                                                                                                                                                                                                                                                                                                                                                                      |
| 10.0 day    | Administration may be repeated at 5 to 10 day intervals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 3.0 day     | The dose is repeated at 3-day intervals until a satisfactory therapeutic response is observed.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 3.0 day     | A maintenance regimen is then initiated which consists of 1 mL per 40 lbs of body weight with a minimum dosage of 1/4 mL which is repeated every 3 days or 7 days, or longer, as required to maintain continued improvement or an asymptomatic condition; or the drug may be used in capsule form for oral maintenance therapy.                                                                                                                                                                                                                                              |
| 7.0 day     | A maintenance regimen is then initiated which consists of 1 mL per 40 lbs of body weight with a minimum dosage of 1/4 mL which is repeated every 3 days or 7 days, or longer, as required to maintain continued improvement or an asymptomatic condition; or the drug may be used in capsule form for oral maintenance therapy.                                                                                                                                                                                                                                              |
| 2.0 week    | Lambs 2 weeks of age or older: 1 milliliter per 40 pounds, minimum 1 milliliter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 30.0 day    | Calves: Discontinue use 30 days before treated calves are slaughtered for human consumption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 14.0 day    | Lambs, ewes, sows, or pigs: Discontinue use 14 days before treated lambs, ewes, sows, or pigs are slaughtered for human consumption.                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 30.0 day    | Breeding beef cows: 1 milliliter per 200 pounds of body weight during the middle third of gestation, and 30 days before calving.                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 30.0 day    | Discontinue use 30 days before treated cattle are slaughtered for human consumption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 2.0 week    | Lambs 2 weeks of age or older: 4 milliliters.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 14.0 day    | Discontinue use 14 days before treated animals are slaughtered for human consumption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 14.0 day    | Inject 500 mg every 14 days starting during the 9th or 10th week (57 to 70 days) after calving and continue until the end of lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 70.0 day    | Inject 500 mg every 14 days starting during the 9th or 10th week (57 to 70 days) after calving and continue until the end of lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 2.0 week    | Avoid injections within 2 weeks of expected slaughter to minimize injection site blemishes on carcass.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 day     | It is administered as spectinomycin dihydrochloride pentahydrate as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |             (1) Subcutaneously in the treatment of 1-to-3-day-old turkey poults at the rate of 1 to 2 milligrams per poult as an aid in the prevention of mortality associated with Arizona group infection.                                                                                                                                                                                                                                                                                                                                                                 |
| 3.0 day     | (2) Subcutaneously in the treatment of 1-to-3-day old:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 4.0 day     | Treatment may be continued for 4 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 day     | (4) Administer single injection of 0.1 milliliter (10 milligrams) subcutaneously in nape of neck of 1- to 3-day-old turkey poults as an aid in control of airsacculitis associated with M. meleagridis sensitive to spectinomycin.                                                                                                                                                                                                                                                                                                                                           |
| 24.0 hour   | 10 to 15 mg per kilogram of body weight at 24-hour intervals for 3 to 5 consecutive days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 11.0 day    | Do not slaughter within 11 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 20.0 month  | Do not use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 4.0 week    | Administer 25 mg per 100 pounds of body weight by deep intramuscular injection in the gluteal region at weekly intervals, for not more than 4 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 5.0 day     | Administer 30 to 45 mg per pound (/lb) of body weight in divided doses by twice daily injection for 1 to 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 5.0 day     | Treated calves must not be slaughtered for food during treatment or for 5 days after the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 24.0 hour   | Administer by subcutaneous, intramuscular, or intravenous injection at an initial dose of 25 mg per pound of body weight followed by 12.5 mg per pound of body weight every 24 hours thereafter.                                                                                                                                                                                                                                                                                                                                                                             |
| 48.0 hour   | Continue treatment until the animal is free from symptoms for 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 24.0 hour   | Administer by intravenous or subcutaneous injection at an initial dose of 55 mg per kilogram of body weight followed by 27.5 mg per kilogram of body weight every 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                  |
| 24.0 hour   | Administer by intravenous injection at an initial dose of 55 mg per kilogram of body weight followed by 27.5 mg per kilogram of body weight every 24 hours until the patient is asymptomatic for 48 hours.                                                                                                                                                                                                                                                                                                                                                                   |
| 48.0 hour   | Administer by intravenous injection at an initial dose of 55 mg per kilogram of body weight followed by 27.5 mg per kilogram of body weight every 24 hours until the patient is asymptomatic for 48 hours.                                                                                                                                                                                                                                                                                                                                                                   |
| 24.0 hour   | Administer an initial dose of 25 mg per pound of body weight by intravenous injection followed by 12.5 mg per pound of body weight every 24 hours until the animal is asymptomatic for 48 hours.                                                                                                                                                                                                                                                                                                                                                                             |
| 48.0 hour   | Administer an initial dose of 25 mg per pound of body weight by intravenous injection followed by 12.5 mg per pound of body weight every 24 hours until the animal is asymptomatic for 48 hours.                                                                                                                                                                                                                                                                                                                                                                             |
| 60.0 hour   | Milk taken from animals during treatment and for 60 hours (5 milkings) after the latest treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 5.0 day     | Do not administer within 5 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 4.0 day     | Administer 2.5 grams per 100 pounds of body weight per day by intravenous injection for not more than 4 days; or first treatment may be followed by 3 days of treatment with sulfaethoxypyridazine in drinking water or tablets in accordance with &#167;&#167;&#8201;520.2240a(e) and 520.2240b(e) of this chapter.                                                                                                                                                                                                                                                         |
| 3.0 day     | Administer 2.5 grams per 100 pounds of body weight per day by intravenous injection for not more than 4 days; or first treatment may be followed by 3 days of treatment with sulfaethoxypyridazine in drinking water or tablets in accordance with &#167;&#167;&#8201;520.2240a(e) and 520.2240b(e) of this chapter.                                                                                                                                                                                                                                                         |
| 16.0 day    | Do not treat within 16 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 72.0 hour   | Milk that has been taken from animals during treatment and for 72 hours (6 milkings) after the latest treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.0 day    | Withdraw medication from cattle 10 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 20.0 month  | Do not use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.0 day     | (2) It is administered by subcutaneous injection as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |             (3) A second injection may be given 3 days later if symptoms persist.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 5.0 day     | (4) Not for use in laying hens; do not treat chickens within 5 days of slaughter; do not treat turkeys within 7 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 7.0 day     | (4) Not for use in laying hens; do not treat chickens within 5 days of slaughter; do not treat turkeys within 7 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 30.0 minute | For horses, it is recommended that a pre-anesthetic sedation be administered to the horse 30 minutes before the drug is administered.                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 10.0 minute | Administer by intravenous injection as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|             |             (i) 6 to 9 milligrams (mg) per pound of body weight for brief anesthesia (6 to 10 minutes).                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 25.0 minute | (ii) 10 to 12 mg per pound of body weight for anesthesia of 15 to 25 minutes duration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 5.0 minute  | For total anesthesia, it is given at approximately 10 to 12 mg per pound of body weight over a period of 3.5 to 5 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 21.0 day    | Cattle intended for human consumption must not be slaughtered within 21 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 20.0 month  | Do not use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 30.0 minute | For restraint or for anesthesia combined with muscle relaxation in cats and in dogs for restraint and minor procedures of short duration (30 minutes average) requiring mild to moderate analgesia.                                                                                                                                                                                                                                                                                                                                                                          |
| 20.0 month  | Do not use in female dairy cattle 20 months of age or older.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 42.0 day    | Do not slaughter within 42 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 28.0 day    | Do not slaughter within 28 days of last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 126.0 day   | Use 126 days prior to slaughter; should be reimplanted once after 63 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 63.0 day    | Use 126 days prior to slaughter; should be reimplanted once after 63 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 63.0 day    | Use last 63 days prior to slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 200.0 day   | For increased rate of weight gain and improved feed efficiency during 70 to 200 days after implantation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 200.0 day   | For increased rate of weight gain and improved feed efficiency for up to 200 days after implantation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 200.0 day   | For increased rate of weight gain and improved feed efficiency for up to 200 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 200.0 day   | For increased rate of weight gain and improved feed efficiency for up to 200 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 200.0 day   | For increased rate of weight gain for up to 200 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 4.0 day     | After 3 or 4 days, repeat dosage if indicated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 4.0 day     | After 3 or 4 days, repeat dosage if indicated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 7.0 day     | 2 mL of the product described in paragraph (a)(2) of this section (160 mg trimethoprim and 800 mg sulfadiazine) per 100 pounds (45 kilograms) of body weight per day by intravenous injection as single, daily dose for 5 to 7 days.                                                                                                                                                                                                                                                                                                                                         |
| 4.0 day     | Treated cattle must not be slaughtered for food during treatment and for 4 days following the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 24.0 hour   | Milk that has been taken during treatment and for 24 hours (two milkings) after the last treatment must not be used for food.                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 18.0 day    | (A) Cattle intended for human consumption must not be slaughtered within 18 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 20.0 month  | This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 22.0 day    | (B) Calves intended for human consumption must not be slaughtered within 22 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 5.0 day     | Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 24.0 hour   | Continue treatment 24 hours after symptoms disappear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | Cattle intended for human consumption must not be slaughtered within 21 days of the last use of this drug product.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 20.0 month  | This drug product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows.                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 24.0 hour   | Continue treatment 24 hours after symptoms disappear.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 2.0 week    | If tylosin medicated drinking water is used as a followup treatment for swine dysentery, the animal should thereafter receive feed containing 40 to 100 grams of tylosin per ton for 2 weeks to assure depletion of tissue residues.                                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | Swine intended for human consumption must not be slaughtered within 14 days of the last use of this drug product.                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 24.0 hour   | Administer 3 to 5 mg/lb of body weight by intramuscular injection at 12- to 24-hour intervals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 15.0 day    | Do not use in Cervidae less than 15 days before or during the hunting season.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 day    | Do not use for 30 days before or during hunting season.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 1.0 month   | Do not use before 1 month of age or after weaning in heifers intended for reproduction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 40.0 day    | Do not implant animals within 40 days of slaughter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.0 month  | Intratesticular injection for chemical sterilization of 3- to 10-month-old male dogs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |


## Condition

| Condition   | Context                                                                                                                                                         |
|:------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| until       | by intravenous injection over approximately 60 seconds or until clinical signs show the onset of anesthesia, 2.2                                                |
| until       | by intravenous injection over approximately 60 seconds or until clinical signs show the onset of anesthesia, 1.5                                                |
| where       | the superficial digital flexor tendon (SDFT) in horses where  there is sonographic evidence of fiber tearing.                                                   |
| when        | to Staphylococcus spp., Streptococcus spp., and E. coli, when  caused by susceptible organisms.                                                                 |
| when        | spp., Streptococcus spp., E. coli, and P. mirabilis, when  caused by susceptible organisms.                                                                     |
| when        | For control of aggressiveness  when mixing or regrouping weanling or feeder pigs weighing                                                                       |
| when        | Dosage may be repeated every 3 weeks or  when symptoms recur, not to exceed a total of                                                                          |
| when        | Dosage may be repeated every 3 weeks or  when symptoms recur, not to exceed a total of                                                                          |
| when        | animals may induce the first stage of parturition when administered during the last trimester of pregnancy and                                                  |
| when        | As an aid for treating debilitated horses  when an improvement in weight, hair coat, or general                                                                 |
| if          | of 3.6 mg/lb (8 mg/kg) may be administered if  response to therapy is not complete.                                                                             |
| where       | parasuis, and S. suis in groups of pigs where  SRD has been diagnosed.                                                                                          |
| where       | injection in the posterior aspect of the ear where it attaches to the head (base of the                                                                         |
| until       | 100 pounds of body weight by intravenous injection until  the desired effect is produced.                                                                       |
| until       | pregnant feedlot heifers from 1 week after mating until  41/2 months of gestation.                                                                              |
| until       | pregnancies from mismatings from 1 week after mating until 5 months after conception; for treating unobserved (nondetected)                                     |
| where       | For stimulation of the adrenal cortex  where  there is a general deficiency of corticotropin (ACTH).                                                            |
| where       | ketosis; and for stimulation of the adrenal cortex where  there is a general deficiency of ACTH.                                                                |
| when        | cattle for the prevention of copper deficiency, or when labeled for veterinary prescription use, for the prevention                                             |
| if          | intravenously or intramuscularly and dosage may be repeated if  necessary, as follows:                                                                          |
|             |             (A) Dogs.                                                                                                                                           |
| until       | injection, repeated for 3 to 5 days or until  a response is noted.                                                                                              |
| until       | 12 hours, for 3 to 5 days or until the urine is free of leptospira for at                                                                                       |
| when        | For parturition induction in swine  when  injected within 3 days of normal predicted farrowing.                                                                 |
| if          | may be repeated in 15 to 20 minutes if  necessary.                                                                                                              |
| if          | may be repeated at 8 to 12 hours, if  necessary, to produce desired effect.                                                                                     |
| where       | colibacillosis in groups or pens of weaned pigs where  colibacillosis associated with Escherichia coli has been diagnosed.                                      |
| when        | Those that do not conceive can be re-bred  when they return to estrus approximately 17 to 25                                                                    |
| when        | and other respiratory problems should exercise extreme caution when  handling this product.                                                                     |
| when        | and amount&#8212;(A) For feedlot heifers to induce abortion when pregnant 150 days or less, administer 1 mg                                                     |
| where       | disease states involving synovial structures (joints) of horses where excessive synovial fluid of inflammatory origin is present                                |
| where       | disease states involving synovial structures (joints) of horses where excessive synovial fluid of inflammatory origin is present                                |
| where       | the treatment of musculoskeletal conditions due to inflammation, where permanent structural changes do not exist, e.g., bursitis,                               |
| where       | inflammation of muscles or joints and accessory structures where permanent structural changes do not exist, e.g., arthritis,                                    |
| as soon as  | (200 mg iron) per pig by intramuscular injection as soon as  signs of deficiency appear.                                                                        |
| if          | Dosage may be repeated in 14 days  if the animal's behavior or examination of the ovaries                                                                       |
| until       | clinical signs, urinalysis results, and glucose curve values until  adequate glycemic control has been attained.                                                |
| if          | Twice-daily therapy should be initiated  if the duration of insulin action is determined to                                                                     |
| until       | clinical signs, urinalysis results, and glucose curve values until  adequate glycemic control has been attained.                                                |
| until       | based on both clinical signs and glucose nadirs until  adequate glycemic control has been attained.                                                             |
| subject to  | included with the drug, all such uses are subject to  the labeling requirements of &#167;&#8201;201.105 of this chapter.                                        |
| when        | and other respiratory problems should exercise extreme caution when  handling this product.                                                                     |
| when        | inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when  administered prior to surgery.                                        |
| if          | Dosage may be continued beyond 5 weeks  if  satisfactory improvement has not been achieved.                                                                     |
| if          | is present, response will occur much more slowly, if  at all.                                                                                                   |
| where       | mg/lb BW intramuscularly or subcutaneously as single dosage where retreatment of calves and yearlings for bacterial pneumonia                                   |
| where       | mg/lb BW intramuscularly or subcutaneously as single dosage where retreatment of calves and yearlings for bacterial pneumonia                                   |
| where       | (C) 9 mg/lb BW as a single dosage  where  retreatment for pneumonia is impractical.                                                                             |
| where       | mg/lb BW intramuscularly or subcutaneously as single dosage where retreatment of calves and yearlings for bacterial pneumonia                                   |
| where       | mg/lb BW intramuscularly or subcutaneously as single dosage where retreatment of calves and yearlings for bacterial pneumonia                                   |
| where       | (C) 9 mg/lb BW as a single dosage  where  retreatment for pneumonia is impractical.                                                                             |
| if          | Consult your veterinarian  if  no improvement is noted within 48 hours.                                                                                         |
| if          | pound of body weight per day for anaplasmosis. if                                                                                                               |
| when        | more than 10 milliliters at any one site. when                                                                                                                  |
| when        | Intravenous administration is recommended in cattle  when  daily dosage exceeds 50 milliliters.                                                                 |
| unless      | Do not administer to laying hens  unless  the eggs are used for hatching only.                                                                                  |
| if          | Consult your veterinarian  if  no improvement is noted within 48 hours.                                                                                         |
| if          | wound infections caused by staphylococcal and streptococcal organisms; if labeled for use by or on the order                                                    |
| where       | oxytetracycline and 0.9 mg flunixin per lb BW) where retreatment of calves and yearlings for bacterial pneumonia                                                |
| where       | oxytetracycline and 0.9 mg flunixin per lb BW) where retreatment of calves and yearlings for bacterial pneumonia                                                |
| if          | cells of the mammary gland for milk letdown if  the udder is in proper physiological state.                                                                     |
| as soon as  | Administer  as soon as  possible after exposure to the poison.                                                                                                  |
| when        | The dosage rate for sterile pralidoxime chloride  when  administered to horses is 2 g per horse.                                                                |
| if          | pralidoxime chloride may be given after 1 hour if  muscle weakness has not been relieved.                                                                       |
| if          | mL; for 11 to 25 lb, 1.0 mL; if over 25 lb, 0.2 mL/5 lb body weight                                                                                             |
| when        | The dose may be repeated  when  necessary.                                                                                                                      |
| when        | The dosage may be repeated  when  necessary.                                                                                                                    |
| when        | The dose may be repeated  when necessary after 7 days for two or three                                                                                          |
| when        | pre- and postoperatively and for various stress conditions when corticosteroids are required while the animal is being                                          |
| when        | Administer  when a rapid adrenal glucocorticoid and/or anti-inflammatory effect is                                                                              |
| where       | of inflammatory, allergic, and less severe stress conditions, where immediate effect is not required, at 1 to                                                   |
| if          | hours and continued for 3 to 5 days if  necessary.                                                                                                              |
| if          | 100 to 400 mg by intramuscular injection, repeating if  necessary.                                                                                              |
| until       | intramuscular injection for 3 to 5 days or until  a response is noted.                                                                                          |
| where       | doses to effect; for induction of general anesthesia where  maintenance is provided by inhalant anesthetics.                                                    |
| if          | may be repeated every 6 to 12 hours if  necessary.                                                                                                              |
| until       | The dose is repeated at 3-day intervals  until  a satisfactory therapeutic response is observed.                                                                |
| until       | (57 to 70 days) after calving and continue until  the end of lactation.                                                                                         |
| when        | activity from spectinomycin dihydrochloride pentahydrate: (1) 5 milligrams when used as provided in paragraph (d)(1) of this                                    |
| when        | (2) [Reserved]                                                                                                                                                  |
|             |             (3) 100 milligrams  when used as provided in paragraphs (d) (2), (3),                                                                               |
| until       | Continue treatment  until the animal is free from symptoms for 48                                                                                               |
| when        | respiratory, genitourinary tract, enteric, and soft tissue infections when caused by Streptococci, Staphylococci, Escherichia, Salmonella, Klebsiella, Proteus, |
| until       | per kilogram of body weight every 24 hours until  the patient is asymptomatic for 48 hours.                                                                     |
| until       | per pound of body weight every 24 hours until  the animal is asymptomatic for 48 hours.                                                                         |
| if          | second injection may be given 3 days later if  symptoms persist.                                                                                                |
| when        | Thialbarbitone sodium for injection  when reconstituted with sterile distilled water provides 94 milligrams                                                     |
| when        | Supplemental doses  when required should be less than the initial dose                                                                                          |
| when        | For use in horses  when it is desirable to reverse the effects of                                                                                               |
| unless      | steers and heifers fed in confinement for slaughter) unless otherwise indicated on labeling because safety and effectiveness                                    |
| unless      | labeling (beef heifers fed in confinement for slaughter) unless otherwise indicated on labeling because safety and effectiveness                                |
| if          | After 3 or 4 days, repeat dosage  if  indicated.                                                                                                                |
| if          | After 3 or 4 days, repeat dosage  if  indicated.                                                                                                                |
| where       | For use  where systemic antibacterial action against sensitive organisms is required                                                                            |
| where       | multocida, and M. hyopneumoniae in groups of pigs where  SRD has been diagnosed.                                                                                |
| when        | Erysipelothrix rhusiopathiae; swine dysentery associated with Treponema hyodysenteriae when followed by appropriate medication in the drinking water            |
| when        | Treatment of upper respiratory infections  when  caused by Staphylococci spp.                                                                                   |
| when        | and for feline pneumonitis  when  caused by tylosin-susceptible organisms.                                                                                      |


## Entities

| Entities                                                      | Context                                                                                                                                                                                      |
|:--------------------------------------------------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food                                                          | Food  and Drugs.                                                                                                                                                                             |
| Alfaxalone                                                    | Alfaxalone .                                                                                                                                                                                 |
| Alfaxalone                                                    | Alfaxalone  is a Class IV controlled substance.                                                                                                                                              |
| Amikacin                                                      | Amikacin .                                                                                                                                                                                   |
| Escherichia                                                   | tract infections (cystitis) caused by susceptible strains of Escherichia  coli and Proteus spp.                                                                                              |
| Proteus                                                       | caused by susceptible strains of Escherichia coli and Proteus  spp.                                                                                                                          |
| Pseudomonas                                                   | soft tissue infections caused by susceptible strains of Pseudomonas  spp.                                                                                                                    |
| Aminopentamide                                                | Aminopentamide .                                                                                                                                                                             |
| Dosage                                                        | Dosage may be gradually increased up to a maximum                                                                                                                                            |
| Amoxicillin                                                   | Amoxicillin .                                                                                                                                                                                |
| Streptococcus                                                 | Respiratory infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., Escherichia coli, and Proteus mirabilis; genitourinary infections                  |
| Streptococcus                                                 | Respiratory infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., Escherichia coli, and Proteus mirabilis; genitourinary infections                  |
| Streptococcus                                                 | Respiratory infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., Escherichia coli, and Proteus mirabilis; genitourinary infections                  |
| Streptococcus                                                 | Respiratory infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., Escherichia coli, and Proteus mirabilis; genitourinary infections                  |
| Streptococcus                                                 | Respiratory infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., Escherichia coli, and Proteus mirabilis; genitourinary infections                  |
| Streptococcus                                                 | respiratory infections due to S. aureus, Staphylococcus spp., Streptococcus spp., Haemophilus spp., E. coli, Pasteurella spp., and                                                           |
| Haemophilus                                                   | due to S. aureus, Staphylococcus spp., Streptococcus spp., Haemophilus spp., E. coli, Pasteurella spp., and P. mirabilis;                                                                    |
| Pasteurella                                                   | Staphylococcus spp., Streptococcus spp., Haemophilus spp., E. coli, Pasteurella spp., and P. mirabilis; genitourinary infections (cystitis) due                                              |
| Streptococcus                                                 | respiratory infections due to S. aureus, Staphylococcus spp., Streptococcus spp., Haemophilus spp., E. coli, Pasteurella spp., and                                                           |
| Corynebacterium                                               | aureus, Streptococcus spp., E. coli, P. mirabilis, and Corynebacterium  spp.                                                                                                                 |
| Proteus                                                       | ; gastrointestinal infections due to E. coli,  Proteus  spp., Staphylococcus spp., and Streptococcus spp.                                                                                    |
| Streptococcus                                                 | to E. coli, Proteus spp., Staphylococcus spp., and Streptococcus  spp.                                                                                                                       |
| Streptococcus                                                 | and wounds) due to S. aureus, Staphylococcus spp., Streptococcus  spp., E. coli, and Pasteurella multocida.                                                                                  |
| Pasteurella                                                   | aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella  multocida.                                                                                                        |
| Haemophilus                                                   | fever, pneumonia) due to P. multocida, P. hemolytica, Haemophilus  spp., Staphylococcus spp., and Streptococcus spp.                                                                         |
| Streptococcus                                                 | multocida, P. hemolytica, Haemophilus spp., Staphylococcus spp., and Streptococcus  spp.                                                                                                     |
| Fusobacterium                                                 | and acute necrotic pododermatitis (foot rot) due to  Fusobacterium  necrophorum.                                                                                                             |
| Ampicillin                                                    | Ampicillin  injectable dosage forms.                                                                                                                                                         |
| Ampicillin                                                    | Ampicillin  trihydrate suspension.                                                                                                                                                           |
| Pasteurella                                                   | by Escherichia coli and bacterial pneumonia caused by Pasteurella  spp.                                                                                                                      |
| Pasteurella                                                   | by E. coli and bacterial pneumonia caused by Pasteurella  spp.                                                                                                                               |
| Usual                                                         | Usual  treatment is 3 to 5 days.                                                                                                                                                             |
| Pseudomonas                                                   | of respiratory tract infections due to E. coli, Pseudomonas  spp., Proteus spp., Staphylococcus spp., and Streptococcus spp.                                                                 |
| Proteus                                                       | tract infections due to E. coli, Pseudomonas spp., Proteus  spp., Staphylococcus spp., and Streptococcus spp.                                                                                |
| Streptococcus                                                 | coli, Pseudomonas spp., Proteus spp., Staphylococcus spp., and Streptococcus  spp.                                                                                                           |
| Pseudomonas                                                   | ; tonsillitis due to E. coli,  Pseudomonas  spp., Streptococcus spp., and Staphylococcus spp.                                                                                                |
| Streptococcus                                                 | ; tonsillitis due to E. coli, Pseudomonas spp.,  Streptococcus  spp., and Staphylococcus spp.                                                                                                |
| Streptococcus                                                 | and  Streptococcus  spp.                                                                                                                                                                     |
| Streptococcus                                                 | of the upper respiratory tract (tonsillitis) due to Streptococcus spp., Staphylococcus spp., E. coli, Proteus spp., and                                                                      |
| Proteus                                                       | due to Streptococcus spp., Staphylococcus spp., E. coli, Proteus spp., and Pasteurella spp., and soft tissue infections                                                                      |
| Pasteurella                                                   | spp., Staphylococcus spp., E. coli, Proteus spp., and Pasteurella spp., and soft tissue infections (abscesses, lacerations, and                                                              |
| Streptococcus                                                 | of the upper respiratory tract (tonsillitis) due to Streptococcus spp., Staphylococcus spp., E. coli, Proteus spp., and                                                                      |
| Usual                                                         | Usual  treatment is 3 to 5 days.                                                                                                                                                             |
| Streptococcus                                                 | abscesses, lacerations, and wounds due to Staphylococcus spp., Streptococcus  spp., and Pasteurella spp.                                                                                     |
| Pasteurella                                                   | wounds due to Staphylococcus spp., Streptococcus spp., and Pasteurella  spp.                                                                                                                 |
| Ampicillin                                                    | Ampicillin  trihydrate powder for injection.                                                                                                                                                 |
| Klebsiella                                                    | pneumonia, and bovine pneumonia) caused by Aerobacter spp., Klebsiella spp., Staphylococcus spp., Streptococcus spp., Pasteurella multocida, and                                             |
| Streptococcus                                                 | caused by Aerobacter spp., Klebsiella spp., Staphylococcus spp., Streptococcus  spp., Pasteurella multocida, and Escherichia coli.                                                           |
| Pasteurella                                                   | Aerobacter spp., Klebsiella spp., Staphylococcus spp., Streptococcus spp., Pasteurella  multocida, and Escherichia coli.                                                                     |
| Escherichia                                                   | spp., Staphylococcus spp., Streptococcus spp., Pasteurella multocida, and Escherichia  coli.                                                                                                 |
| Cattle                                                        | Cattle must not be slaughtered for food during treatment                                                                                                                                     |
| Ampicillin                                                    | Ampicillin  sodium.                                                                                                                                                                          |
| Streptococcus                                                 | infections (pneumonia and strangles) due to Staphylococcus spp., Streptococcus  spp.                                                                                                         |
| Proteus                                                       | (including S. equi), Escherichia coli, and  Proteus mirabilis, and skin and soft tissue infections (abscesses                                                                                |
| Streptococcus                                                 | infections (abscesses and wounds) due to Staphylococcus spp., Streptococcus spp., E. coli, and P. mirabilis, when caused                                                                     |
| Arsenamide                                                    | Arsenamide .                                                                                                                                                                                 |
| Dirofilaria                                                   | and prevention of canine heartworm disease caused by Dirofilaria  immitis.                                                                                                                   |
| Atipamezole                                                   | Atipamezole .                                                                                                                                                                                |
| Inject                                                        | Inject intramuscularly the same volume as that of dexmedetomidine                                                                                                                            |
| Azaperone                                                     | Azaperone .                                                                                                                                                                                  |
| Betamethasone                                                 | Betamethasone .                                                                                                                                                                              |
| Frequency                                                     | Frequency  of dosage depends on recurrence of pruritic symptoms.                                                                                                                             |
| Dosage                                                        | Dosage may be repeated every 3 weeks or when                                                                                                                                                 |
| Betamethasone                                                 | Betamethasone  dipropionate and betamethasone sodium phosphate aqueous suspension.                                                                                                           |
| Betamethasone                                                 | Betamethasone dipropionate and betamethasone sodium phosphate aqueous suspension is                                                                                                          |
| Frequency                                                     | Frequency  of dosage depends on recurrence of pruritic symptoms.                                                                                                                             |
| Dosage                                                        | Dosage may be repeated every 3 weeks or when                                                                                                                                                 |
| Dosage                                                        | Dosage  may be repeated upon recurrence of clinical signs.                                                                                                                                   |
| Injection                                                     | Injection into the joint cavity should be preceded by                                                                                                                                        |
| Betamethasone                                                 | Betamethasone  sodium phosphate and betamethasone acetate.                                                                                                                                   |
| Boldenone                                                     | Boldenone .                                                                                                                                                                                  |
| Treatment                                                     | Treatment  may be repeated at 3-week intervals.                                                                                                                                              |
| Bupivacaine                                                   | Bupivacaine .                                                                                                                                                                                |
| Buprenorphine                                                 | Buprenorphine .                                                                                                                                                                              |
| Butamisole                                                    | Butamisole .                                                                                                                                                                                 |
| Butorphanol                                                   | Butorphanol .                                                                                                                                                                                |
| Treatment                                                     | Treatment should not normally be required for longer than                                                                                                                                    |
| Dose                                                          | Dose may be repeated up to 4 times per                                                                                                                                                       |
| Dose                                                          | Dose  may be repeated within 3 to 4 hours.                                                                                                                                                   |
| Treatment                                                     | Treatment  should not exceed 48 hours.                                                                                                                                                       |
| Carfentanil                                                   | Carfentanil .                                                                                                                                                                                |
| Cervidae                                                      | free ranging and confined members of the family Cervidae  (deer, elk, and moose).                                                                                                            |
| Carprofen                                                     | Carprofen .                                                                                                                                                                                  |
| Cefovecin                                                     | Cefovecin .                                                                                                                                                                                  |
| Streptococcus                                                 | caused by susceptible strains of Staphylococcus intermedius and Streptococcus  canis (Group G).                                                                                              |
| Pasteurella                                                   | abscesses) in cats caused by susceptible strains of Pasteurella  multocida.                                                                                                                  |
| Ceftiofur                                                     | Ceftiofur  injectable dosage forms.                                                                                                                                                          |
| Ceftiofur                                                     | Ceftiofur  crystalline free acid.                                                                                                                                                            |
| Pasteurella                                                   | swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella  multocida, Haemophilus parasuis, and Streptococcus suis.                                       |
| Haemophilus                                                   | disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus  parasuis, and Streptococcus suis.                                                         |
| Streptococcus                                                 | with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, and Streptococcus  suis.                                                                                  |
| Cattle                                                        | (2)  Cattle .                                                                                                                                                                                |
| Pasteurella                                                   | (BRD, shipping fever, pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef, non-lactating dairy,                                          |
| Histophilus                                                   | pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef, non-lactating dairy, and lactating dairy                                            |
| Fusobacterium                                                 | of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii in beef, non-lactating dairy,                                            |
| Porphyromonas                                                 | rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii in beef, non-lactating dairy, and lactating dairy                                       |
| Streptococcus                                                 | infections in horses caused by susceptible strains of Streptococcus  equi ssp.                                                                                                               |
| Ceftiofur                                                     | Ceftiofur  hydrochloride.                                                                                                                                                                    |
| Treatment                                                     | Treatment should be repeated at 24-hour intervals for a                                                                                                                                      |
| Pasteurella                                                   | disease (swine bacterial pneumonia) associated with Actinobacillus pleuropneumoniae, Pasteurella  multocida, Salmonella Choleraesuis, and Streptococcus suis.                                |
| Streptococcus                                                 | with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis, and Streptococcus  suis.                                                                               |
| Fusobacterium                                                 | bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus; and acute metritis (0                              |
| Bacteroides                                                   | (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus; and acute metritis (0 to 14 days                                                       |
| Ceftiofur                                                     | Ceftiofur  sodium.                                                                                                                                                                           |
| Pasteurella                                                   | disease (swine bacterial pneumonia) associated with Actinobacillus pleuropneumoniae, Pasteurella  multocida, Salmonella choleraesuis, and Streptococcus suis.                                |
| Salmonella                                                    | bacterial pneumonia) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella  choleraesuis, and Streptococcus suis.                                               |
| Streptococcus                                                 | with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis, and Streptococcus  suis.                                                                               |
| Pasteurella                                                   | disease (shipping fever, pneumonia) associated with Mannheimia haemolytica, Pasteurella  multocida, and Histophilus somni.                                                                   |
| Histophilus                                                   | pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus  somni.                                                                                            |
| Fusobacterium                                                 | bovine interdigital necrobacillosis (foot rot, pododermatitis) associated with Fusobacterium  necrophorum and Bacteroides melaninogenicus.                                                   |
| Bacteroides                                                   | (foot rot, pododermatitis) associated with Fusobacterium necrophorum and Bacteroides  melaninogenicus.                                                                                       |
| Pasteurella                                                   | disease (sheep pneumonia) associated with Mannheimia haemolytica and Pasteurella  multocida.                                                                                                 |
| Pasteurella                                                   | disease (goat pneumonia) associated with Mannheimia haemolytica and Pasteurella  multocida.                                                                                                  |
| Chickens                                                      | (5)  Chickens &#8212;(i) Amount.                                                                                                                                                             |
| Treatment                                                     | Treatment should be repeated every 24 hours, continued for                                                                                                                                   |
| Treatment                                                     | Treatment should be repeated at 24-hour intervals for 5                                                                                                                                      |
| Proteus                                                       | urinary tract infections associated with E. coli and Proteus  mirabilis.                                                                                                                     |
| Cattle                                                        | Cattle usually require a lower dosage on the basis                                                                                                                                           |
| Chloramphenicol                                               | Chloramphenicol .                                                                                                                                                                            |
| Dogs                                                          | Dogs &#8212;(1) Amount.                                                                                                                                                                      |
| Clodronate                                                    | Clodronate .                                                                                                                                                                                 |
| Cloprostenol                                                  | Cloprostenol .                                                                                                                                                                               |
| Colistimethate                                                | Colistimethate  sodium powder for injection.                                                                                                                                                 |
| Cupric                                                        | Cupric  glycinate injection.                                                                                                                                                                 |
| Danofloxacin                                                  | Danofloxacin .                                                                                                                                                                               |
| Pasteurella                                                   | respiratory disease (BRD) associated with Mannheimia haemolytica and Pasteurella  multocida; or                                                                                              |
| Initial                                                       | Initial dose of 1 milligram per pound (0.45 kilogram)                                                                                                                                        |
| Usual                                                         | Usual dose is 0.75 to 1.0 milligram per pound                                                                                                                                                |
| Detomidine                                                    | Detomidine .                                                                                                                                                                                 |
| Dexamethasone                                                 | Dexamethasone  solution.                                                                                                                                                                     |
| Dexamethasone                                                 | Dexamethasone  solution.                                                                                                                                                                     |
| Cattle                                                        | (D)  Cattle .                                                                                                                                                                                |
| Dexamethasone                                                 | Dexamethasone  suspension.                                                                                                                                                                   |
| Dosage                                                        | Dosage  may be repeated.                                                                                                                                                                     |
| Dexmedetomidine                                               | Dexmedetomidine .                                                                                                                                                                            |
| Diatrizoate                                                   | Diatrizoate .                                                                                                                                                                                |
| Dihydrostreptomycin                                           | Dihydrostreptomycin  sulfate injection.                                                                                                                                                      |
| Leptospira                                                    | of leptospirosis in dogs and horses due to Leptospira canicola, L. icterohemorrhagiae, and L. pomona; in cattle                                                                              |
| Discontinue                                                   | Discontinue  use 30 days before slaughter for food.                                                                                                                                          |
| Dinoprost                                                     | Dinoprost .                                                                                                                                                                                  |
| Cattle                                                        | (d) Conditions of use&#8212;(1)  Cattle .                                                                                                                                                    |
| Cattle                                                        | (4)  Cattle .                                                                                                                                                                                |
| Indications                                                   | (B)  Indications .                                                                                                                                                                           |
| Indications                                                   | (B)  Indications .                                                                                                                                                                           |
| Indications                                                   | (B)  Indications .                                                                                                                                                                           |
| Indications                                                   | (B)  Indications .                                                                                                                                                                           |
| Diprenorphine                                                 | Diprenorphine .                                                                                                                                                                              |
| Distribution                                                  | Distribution is restricted to veterinarians engaged in zoo and                                                                                                                               |
| Doramectin                                                    | Doramectin .                                                                                                                                                                                 |
| Cooperia                                                      | control infections and to protect from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia                                                                     |
| Ostertagia                                                    | Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum                                                                     |
| Oesophagostomum                                               | Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after                                                                    |
| Dictyocaulus                                                  | 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus  viviparus for 28 days after treatment.                                                                                 |
| Doxapram                                                      | Doxapram .                                                                                                                                                                                   |
| Dosage                                                        | Dosage may be repeated in 15 to 20 minutes                                                                                                                                                   |
| Doxylamine                                                    | Doxylamine .                                                                                                                                                                                 |
| Droperidol                                                    | Droperidol  and fentanyl.                                                                                                                                                                    |
| Embutramide                                                   | Embutramide , chloroquine, and lidocaine solution.                                                                                                                                           |
| U.S.P                                                         | 135 milligrams (mg) embutramide; 45 mg chloroquine phosphate, U.S.P .                                                                                                                        |
| U.S.P                                                         | ; and 1.9 mg lidocaine,  U.S.P .                                                                                                                                                             |
| Enrofloxacin                                                  | Enrofloxacin .                                                                                                                                                                               |
| Cattle                                                        | (2)  Cattle .                                                                                                                                                                                |
| Treatment                                                     | Treatment should be repeated at 24-hour intervals for 3                                                                                                                                      |
| Pasteurella                                                   | the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef                                                          |
| Histophilus                                                   | of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating                                                      |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating                                              |
| Histophilus                                                   | (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus  somni in beef and non-lactating dairy cattle.                                                          |
| Pasteurella                                                   | swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica, and             |
| Haemophilus                                                   | disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus  parasuis, Streptococcus suis,                                                             |
|                                                               |               Bordetella bronchiseptica, and Mycoplasma hyopneumoniae.                                                                                                                       |
| Streptococcus                                                 | associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus  suis,                                                                           |
|                                                               |               Bordetella bronchiseptica, and Mycoplasma hyopneumoniae.                                                                                                                       |
| Bordetella                                                    | Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella  bronchiseptica, and Mycoplasma hyopneumoniae.                                  |
| Pasteurella                                                   | swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella  multocida,                                                                                     |
|                                                               |               Haemophilus parasuis, and Streptococcus suis.                                                                                                                                  |
| Haemophilus                                                   | disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus  parasuis, and Streptococcus suis.                                                         |
| Streptococcus                                                 | with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, and Streptococcus  suis.                                                                                  |
| Cooperia                                                      | Gastrointestinal roundworms (adults and fourth-stage larvae) Bunostomum phlebotomum, Cooperia oncophora, C. punctata, C. surnabada, Trichostrongylus axei, Ostertagia                        |
| Trichostrongylus                                              | Bunostomum phlebotomum, Cooperia oncophora, C. punctata, C. surnabada, Trichostrongylus axei, Ostertagia ostertagi (including inhibited stage); (adults) Haemonchus                          |
| Ostertagia                                                    | Cooperia oncophora, C. punctata, C. surnabada, Trichostrongylus axei, Ostertagia ostertagi (including inhibited stage); (adults) Haemonchus placei, Oesophagostomum                          |
| Oesophagostomum                                               | Ostertagia ostertagi (including inhibited stage); (adults) Haemonchus placei, Oesophagostomum radiatum, O. lyrata, T. colubriformis; lungworms (adults) Dictyocaulus                         |
| Erythromycin                                                  | Erythromycin .                                                                                                                                                                               |
| Streptococcus                                                 | and bacterial wound infections caused by Staphylococcus spp., Streptococcus  spp., and Corynebacterium spp., sensitive to erythromycin.                                                      |
| Corynebacterium                                               | infections caused by Staphylococcus spp., Streptococcus spp., and Corynebacterium  spp., sensitive to erythromycin.                                                                          |
| Streptococcus                                                 | and  Streptococcus  spp., susceptible to erythromycin.                                                                                                                                       |
| Cattle                                                        | (3)  Cattle .                                                                                                                                                                                |
| Pasteurella                                                   | (shipping fever complex and bacterial pneumonia) associated with Pasteurella  multocida susceptible to erythromycin.                                                                         |
| Estradiol                                                     | Estradiol .                                                                                                                                                                                  |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Estradiol                                                     | Estradiol  benzoate and testosterone propionate.                                                                                                                                             |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Estradiol                                                     | Estradiol  valerate and norgestomet in combination.                                                                                                                                          |
| Insert                                                        | Insert implant subcutaneously in the ear only; then immediately                                                                                                                              |
| Collect                                                       | Collect all implants as they are removed and burn                                                                                                                                            |
| Ethylisobutrazine                                             | Ethylisobutrazine .                                                                                                                                                                          |
| Etodolac                                                      | Etodolac .                                                                                                                                                                                   |
| Etorphine                                                     | Etorphine .                                                                                                                                                                                  |
| Distribution                                                  | Distribution is restricted to veterinarians engaged in zoo and                                                                                                                               |
| Euthanasia                                                    | Euthanasia  solution.                                                                                                                                                                        |
| Fenprostalene                                                 | Fenprostalene .                                                                                                                                                                              |
| Accidental                                                    | Accidental spillage on the skin should be washed off                                                                                                                                         |
| Firocoxib                                                     | Firocoxib .                                                                                                                                                                                  |
| Florfenicol                                                   | Florfenicol .                                                                                                                                                                                |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef                                              |
| Histophilus                                                   | disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating                                               |
| Mannheimia                                                    | For treatment of BRD associated with  Mannheimia  (Pasteurella) haemolytica, P. multocida, and Haemophilus somnus.                                                                           |
| Haemophilus                                                   | associated with Mannheimia (Pasteurella) haemolytica, P. multocida, and Haemophilus  somnus.                                                                                                 |
| Fusobacterium                                                 | rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with Fusobacterium  necrophorum and Bacteroides melaninogenicus.                                              |
| Bacteroides                                                   | necrobacillosis, infectious pododermatitis) associated with Fusobacterium necrophorum and Bacteroides  melaninogenicus.                                                                      |
| Mannheimia                                                    | at high risk of developing BRD associated with Mannheimia  (Pasteurella) haemolytica, P. multocida, and Haemophilus somnus.                                                                  |
| Haemophilus                                                   | associated with Mannheimia (Pasteurella) haemolytica, P. multocida, and Haemophilus  somnus.                                                                                                 |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis, and control                                         |
| Histophilus                                                   | disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis, and control of BRD-associated                                          |
| Flumethasone                                                  | Flumethasone  injectable dosage forms.                                                                                                                                                       |
| Dosage                                                        | Dosage is limited to a single injection per week                                                                                                                                             |
| Dosage                                                        | Dosage should be adjusted according to the weight of                                                                                                                                         |
| Dosage                                                        | Dosage by injection should not exceed 3 days of                                                                                                                                              |
| Flunixin                                                      | Flunixin .                                                                                                                                                                                   |
| Approved                                                      | Approved  only for intravenous administration in cattle.                                                                                                                                     |
| Cattle                                                        | Cattle must not be slaughtered for human consumption within                                                                                                                                  |
| Swine                                                         | Swine must not be slaughtered for human consumption within                                                                                                                                   |
| Fluprostenol                                                  | Fluprostenol .                                                                                                                                                                               |
| Single                                                        | (b)(1) Specifications&#8212;(i)  Single  pack.                                                                                                                                               |
| Furosemide                                                    | Furosemide .                                                                                                                                                                                 |
| Cattle                                                        | Cattle must not be slaughtered for food within 48                                                                                                                                            |
| Gamithromycin                                                 | Gamithromycin .                                                                                                                                                                              |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef                                              |
| Histophilus                                                   | disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating                                               |
| Cattle                                                        | Cattle intended for human consumption must not be slaughtered                                                                                                                                |
| Gentamicin                                                    | Gentamicin .                                                                                                                                                                                 |
| Arizona                                                       | in the prevention of early mortality due to Arizona  paracolon infections susceptible to gentamicin.                                                                                         |
| Chickens                                                      | (3)  Chickens &#8212;(i) Amount.                                                                                                                                                             |
| Salmonella                                                    | Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to                                                                                                                   |
| Pseudomonas                                                   | Salmonella typhimurium, and  Pseudomonas  aeruginosa that are susceptible to gentamicin.                                                                                                     |
| Gleptoferron                                                  | Gleptoferron .                                                                                                                                                                               |
| Gonadorelin                                                   | Gonadorelin .                                                                                                                                                                                |
| Serum                                                         | Serum  gonadotropin and chorionic gonadotropin.                                                                                                                                              |
| Delayed                                                       | Delayed return to estrus is most prevalent after the                                                                                                                                         |
| Delayed                                                       | Delayed return to estrus often occurs during periods of                                                                                                                                      |
| Chorionic                                                     | Chorionic  gonadotropin.                                                                                                                                                                     |
| Dosage                                                        | Dosage may be repeated in 14 days if the                                                                                                                                                     |
| Guaifenesin                                                   | Guaifenesin  powder for injection.                                                                                                                                                           |
| Guaifenesin                                                   | Guaifenesin  solution.                                                                                                                                                                       |
| Hemoglobin                                                    | Hemoglobin  glutamer-200 (bovine).                                                                                                                                                           |
| Hyaluronate                                                   | Hyaluronate .                                                                                                                                                                                |
| Small                                                         | Small and medium-size joints (carpal, fetlock): 20 mg; larger                                                                                                                                |
| Treatment                                                     | Treatment may be repeated at weekly intervals for a                                                                                                                                          |
| Small                                                         | Small and medium-size joints (carpal, fetlock): 10 mg; larger                                                                                                                                |
| Treatment                                                     | Treatment may be repeated at weekly intervals for a                                                                                                                                          |
| Small                                                         | Small  and medium-size joints (carpal, fetlock): 20 mg.                                                                                                                                      |
| Treatment                                                     | Treatment may be repeated after 1 or more weeks                                                                                                                                              |
| Treatment                                                     | Treatment may be repeated at weekly intervals for a                                                                                                                                          |
| Small                                                         | Small and medium-size joints (carpal, fetlock): 22 mg; larger                                                                                                                                |
| Treatment                                                     | Treatment may be repeated at weekly intervals for a                                                                                                                                          |
| Hydrochlorothiazide                                           | Hydrochlorothiazide .                                                                                                                                                                        |
| Imidocarb                                                     | Imidocarb  powder for injection.                                                                                                                                                             |
| Imidocarb                                                     | Imidocarb dipropionate is sold only under permit issued by                                                                                                                                   |
| U.S. Department                                               | Veterinary Services, Animal and Plant Health Inspection Service, U.S. Department of Agriculture, to licensed or full-time State, Federal,                                                    |
| Agriculture                                                   | and Plant Health Inspection Service, U.S. Department of Agriculture , to licensed or full-time State, Federal, or                                                                            |
| Babesia                                                       | For  Babesia caballi infections, administer 2 mg of imidocarb base                                                                                                                           |
| Babesia                                                       | For  Babesia equi infections, administer 4 mg of imidocarb base                                                                                                                              |
| Babesia                                                       | For the treatment of babesiosis (piroplasmosis) caused by  Babesia  caballi and                                                                                                              |
| Babesia                                                       | For the treatment of babesiosis (piroplasmosis) caused by  Babesia  caballi and                                                                                                              |
| Imidocarb                                                     | Imidocarb  solution.                                                                                                                                                                         |
| Babesia                                                       | treatment of clinical signs of babesiosis and/or demonstrated Babesia  organisms in the blood.                                                                                               |
| Insulin                                                       | Insulin .                                                                                                                                                                                    |
| Porcine                                                       | (2) Cats&#8212;(i) Amount&#8212;(A)  Porcine  insulin zinc.                                                                                                                                  |
| Iron                                                          | Iron  injection.                                                                                                                                                                             |
| Dosage                                                        | Dosage  may be repeated in approximately 10 days.                                                                                                                                            |
| Dosage                                                        | Dosage  may be repeated in 14 to 21 days.                                                                                                                                                    |
| Dosage                                                        | Dosage may be repeated in 10 days to 2                                                                                                                                                       |
| Dosage                                                        | Dosage  may be repeated at 2 weeks of age.                                                                                                                                                   |
| Treatment                                                     | Treatment  may be repeated in 10 days.                                                                                                                                                       |
| Isoflupredone                                                 | Isoflupredone .                                                                                                                                                                              |
| Swine                                                         | (B)  Swine .                                                                                                                                                                                 |
| Ivermectin                                                    | Ivermectin .                                                                                                                                                                                 |
| Triodontophorus                                               | of large strongyles (adult) (Strongylus vulgaris, S. edentatus, Triodontophorus  spp.                                                                                                        |
| Cylicocyclus                                                  | strongyles (adult and fourth stage larvae) (Cyathostomum spp., Cylicocyclus  spp., Cylicostephanus spp.                                                                                      |
| Cylicostephanus                                               | and fourth stage larvae) (Cyathostomum spp., Cylicocyclus spp., Cylicostephanus  spp.                                                                                                        |
| Ostertagia                                                    | gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei,                         |
| Trichostrongylus                                              | placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctata, C.                                           |
| Cooperia                                                      | inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctata, C. pectinata, Oesophagostomum radiatum, Nematodirus                                  |
| Oesophagostomum                                               | T. colubriformis, Cooperia oncophora, C. punctata, C. pectinata, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults                                       |
| Nematodirus                                                   | Cooperia oncophora, C. punctata, C. pectinata, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum                                       |
| Bunostomum                                                    | Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum); lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparus);                             |
| Haematopinus                                                  | (Hypoderma bovis, H. lineatum); sucking lice (Linognathus vituli, Haematopinus  eurysternus, Solenopotes capillatus); mites (scabies) (Psoroptes ovis (syn.                                  |
| Solenopotes                                                   | H. lineatum); sucking lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes  capillatus); mites (scabies) (Psoroptes ovis (syn.                                                    |
| Ascaris                                                       | gastrointestinal roundworms (adults and fourth-stage larvae) (large roundworm, Ascaris suum; red stomach worm, Hyostrongylus rubidus; nodular worm,                                          |
| Hyostrongylus                                                 | larvae) (large roundworm, Ascaris suum; red stomach worm, Hyostrongylus  rubidus; nodular worm, Oesophagostomum spp.                                                                         |
| Oesophagostomum                                               | suum; red stomach worm, Hyostrongylus rubidus; nodular worm, Oesophagostomum  spp.                                                                                                           |
| Strongyloides                                                 | ; threadworm,  Strongyloides ransomi (adults only)); somatic roundworm larvae (threadworm, S.                                                                                                |
| Repeat                                                        | Repeat  in 3 weeks.                                                                                                                                                                          |
| Ivermectin                                                    | Ivermectin  and clorsulon.                                                                                                                                                                   |
| Ostertagia                                                    | gastrointestinal nematodes (adults and fourth-stage larvae) (Haemonchus placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei,                         |
| Trichostrongylus                                              | placei, Ostertagia ostertagi (including inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctata, C.                                           |
| Cooperia                                                      | inhibited larvae), O. lyrata, Trichostrongylus axei, T. colubriformis, Cooperia oncophora, C. punctata, C. pectinata, Oesophagostomum radiatum, Nematodirus                                  |
| Oesophagostomum                                               | T. colubriformis, Cooperia oncophora, C. punctata, C. pectinata, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults                                       |
| Nematodirus                                                   | Cooperia oncophora, C. punctata, C. pectinata, Oesophagostomum radiatum, Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum                                       |
| Bunostomum                                                    | Nematodirus helvetianus (adults only), N. spathiger (adults only), Bunostomum phlebotomum; lungworms (adults and fourth-stage larvae) (Dictyocaulus viviparus);                              |
| Haematopinus                                                  | stages) (Hypoderma bovis, H. lineatum); lice (Linognathus vituli, Haematopinus  eurysternus, Solenopotes capillatus); mites (Psoroptes ovis (syn.                                            |
| Solenopotes                                                   | bovis, H. lineatum); lice (Linognathus vituli, Haematopinus eurysternus, Solenopotes  capillatus); mites (Psoroptes ovis (syn.                                                               |
| Kanamycin                                                     | Kanamycin .                                                                                                                                                                                  |
| Ketamine                                                      | Ketamine .                                                                                                                                                                                   |
| Ketamine                                                      | Ketamine , promazine, and aminopentamide.                                                                                                                                                    |
| Ketoprofen                                                    | Ketoprofen .                                                                                                                                                                                 |
| Levamisole                                                    | Levamisole .                                                                                                                                                                                 |
| Trichostrongylus, Ostertagia                                  | treatment of the following parasites: stomach worms (Haemonchus, Trichostrongylus, Ostertagia ), intestinal worms (Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Oesophagostomum,     |
| Cooperia, Nematodirus, Bunostomum, Oesophagostomum, Chabertia | stomach worms (Haemonchus, Trichostrongylus, Ostertagia), intestinal worms (Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Oesophagostomum, Chabertia ), and lungworms (Dictyocaulus). |
| Trichostrongylus, Ostertagia                                  | treatment of the following parasites: stomach worms (Haemonchus, Trichostrongylus, Ostertagia ), intestinal worms (Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Oesophagostomum)     |
| Cooperia, Nematodirus, Bunostomum, Oesophagostomum            | stomach worms (Haemonchus, Trichostrongylus, Ostertagia), intestinal worms (Trichostrongylus, Cooperia, Nematodirus, Bunostomum, Oesophagostomum ) and lungworms (Dictyocaulus).             |
| Lincomycin                                                    | Lincomycin .                                                                                                                                                                                 |
| Lufenuron                                                     | Lufenuron .                                                                                                                                                                                  |
| Luprostiol                                                    | Luprostiol .                                                                                                                                                                                 |
| Luprostiol                                                    | Luprostiol is readily absorbed through the skin and can                                                                                                                                      |
| Direct                                                        | Direct  contact with the skin should therefore be avoided.                                                                                                                                   |
| Accidental                                                    | Accidental spillage on the skin should be washed off                                                                                                                                         |
| Maropitant                                                    | Maropitant .                                                                                                                                                                                 |
| Melatonin                                                     | Melatonin  implant.                                                                                                                                                                          |
| Melarsomine                                                   | Melarsomine  powder for injection.                                                                                                                                                           |
| Dirofilaria                                                   | month-old, stage L5) to mature adult infections of Dirofilaria  immitis in dogs.                                                                                                             |
| Meloxicam                                                     | Meloxicam .                                                                                                                                                                                  |
| Mepivacaine                                                   | Mepivacaine .                                                                                                                                                                                |
| Methocarbamol                                                 | Methocarbamol .                                                                                                                                                                              |
| Methylprednisolone                                            | Methylprednisolone .                                                                                                                                                                         |
| Moxidectin                                                    | Moxidectin  solution.                                                                                                                                                                        |
| Haemonchus                                                    | Ostertagia ostertagi (adults, fourth-stage larvae, and inhibited larvae), Haemonchus placei (adults), Trichostrongylus axei (adults and fourth-stage larvae),                                |
| Trichostrongylus                                              | fourth-stage larvae, and inhibited larvae), Haemonchus placei (adults), Trichostrongylus  axei (adults and fourth-stage larvae),                                                             |
| Trichostrongylus                                              | fourth-stage larvae, and inhibited larvae), Haemonchus placei (adults), Trichostrongylus  axei (adults and fourth-stage larvae),                                                             |
| Cooperia                                                      | fourth-stage larvae), Trichostrongylus colubriformis (adults and fourth-stage larvae), Cooperia  oncophora (adults),                                                                         |
| Cooperia                                                      | fourth-stage larvae), Trichostrongylus colubriformis (adults and fourth-stage larvae), Cooperia  oncophora (adults),                                                                         |
| Cooperia                                                      | fourth-stage larvae), Trichostrongylus colubriformis (adults and fourth-stage larvae), Cooperia  oncophora (adults),                                                                         |
| Cooperia                                                      | fourth-stage larvae), Trichostrongylus colubriformis (adults and fourth-stage larvae), Cooperia  oncophora (adults),                                                                         |
| Nematodirus                                                   | spatulata (adults), Cooperia surnabada (adults and fourth-stage larvae), Nematodirus helvetianus (adults), Oesophagostomum radiatum (adults and fourth-stage larvae),                        |
| Oesophagostomum                                               | surnabada (adults and fourth-stage larvae), Nematodirus helvetianus (adults), Oesophagostomum  radiatum (adults and fourth-stage larvae), Trichuris spp.                                     |
| Trichuris                                                     | helvetianus (adults), Oesophagostomum radiatum (adults and fourth-stage larvae), Trichuris  spp.                                                                                             |
| Hypoderma                                                     | lungworms: Dictyocaulus viviparus (adults and fourth-stage larvae); grubs: Hypoderma  bovis and                                                                                              |
| Solenopotes                                                   | bovis); lice: Linognathus vituli and  Solenopotes capillatus; for protection of cattle from reinfection with                                                                                 |
| Moxidectin                                                    | Moxidectin  microspheres for injection.                                                                                                                                                      |
| Dirofilaria                                                   | For prevention of heartworm disease caused by  Dirofilaria immitis; for treatment of existing larval and adult                                                                               |
| Uncinaria                                                     | existing larval and adult hookworm (Ancylostoma caninum) and Uncinaria  stenocephala infections.                                                                                             |
| Nalorphine                                                    | Nalorphine .                                                                                                                                                                                 |
| Respiratory                                                   | Respiratory and circulatory depression in dogs resulting from overdosage                                                                                                                     |
| Naltrexone                                                    | Naltrexone .                                                                                                                                                                                 |
| Naproxen                                                      | Naproxen  for injection.                                                                                                                                                                     |
| Neomycin                                                      | Neomycin .                                                                                                                                                                                   |
| Neostigmine                                                   | Neostigmine .                                                                                                                                                                                |
| Oleate                                                        | Oleate  sodium.                                                                                                                                                                              |
| Orgotein                                                      | Orgotein  for injection.                                                                                                                                                                     |
| Orgotein                                                      | Orgotein for injection is packaged in a vial containing                                                                                                                                      |
| U.S.P                                                         | milliliters of diluent which is sodium chloride injection, U.S.P .                                                                                                                           |
| Dosage                                                        | Dosage may be continued beyond 5 weeks if satisfactory                                                                                                                                       |
| Oxytetracycline                                               | Oxytetracycline  injectable dosage forms.                                                                                                                                                    |
| Oxytetracycline                                               | Oxytetracycline  solution, 200 milligrams/milliliter.                                                                                                                                        |
| Pasteurella                                                   | of pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                                    |
| Haemophilus                                                   | and  Haemophilus spp., foot-rot and diphtheria caused by Fusobacterium necrophorum,                                                                                                          |
| Fusobacterium                                                 | and Haemophilus spp., foot-rot and diphtheria caused by  Fusobacterium necrophorum, bacterial enteritis (scours) caused by Escherichia coli,                                                 |
| Streptococcus                                                 | and  Streptococcus  spp., and anthrax caused by Bacillus anthracis.                                                                                                                          |
| Rapid                                                         | Rapid intravenous administration in cattle may result in animal                                                                                                                              |
| Oxytetracycline                                               | Oxytetracycline should be administered intravenously slowly over a period                                                                                                                    |
| Discontinue                                                   | Discontinue  treatment at least 28 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | colibacillosis) caused by E. coli, pneumonia caused by Pasteurella  multocida, and leptospirosis caused by Leptospira pomona.                                                                |
| Discontinue                                                   | Discontinue  treatment at least 28 days prior to slaughter.                                                                                                                                  |
| Oxytetracycline                                               | Oxytetracycline  solution, 300 milligrams/milliliter.                                                                                                                                        |
| Pasteurella                                                   | of pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                                    |
| Histophilus                                                   | and  Histophilus spp., foot-rot and diphtheria caused by Fusobacterium necrophorum,                                                                                                          |
| Fusobacterium                                                 | and Histophilus spp., foot-rot and diphtheria caused by  Fusobacterium necrophorum, bacterial enteritis (scours) caused by Escherichia coli,                                                 |
| Streptococcus                                                 | and  Streptococcus  spp.                                                                                                                                                                     |
| Mannheimia                                                    | at high risk of developing BRD associated with Mannheimia  (Pasteurella) haemolytica.                                                                                                        |
| Treatment                                                     | Treatment should be continued 24 to 48 hours following                                                                                                                                       |
| Rapid                                                         | Rapid  intravenous administration may result in animal collapse.                                                                                                                             |
| Oxytetracycline                                               | Oxytetracycline should be administered intravenously slowly over a period                                                                                                                    |
| Discontinue                                                   | Discontinue  treatment at least 28 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | colibacillosis) caused by E. coli, pneumonia caused by Pasteurella  multocida, and leptospirosis caused by Leptospira pomona.                                                                |
| Treatment                                                     | Treatment should be continued 24 to 48 hours beyond                                                                                                                                          |
| Discontinue                                                   | Discontinue  treatment at least 28 days prior to slaughter.                                                                                                                                  |
| Oxytetracycline                                               | Oxytetracycline  hydrochloride implantation or injectable dosage forms.                                                                                                                      |
| Oxytetracycline                                               | Oxytetracycline  hydrochloride injection.                                                                                                                                                    |
| Klebsiella                                                    | ;  Klebsiella  spp.                                                                                                                                                                          |
| Leptospirosis                                                 | Leptospirosis , severe foot-rot and severe forms of the                                                                                                                                      |
| Treatment                                                     | Treatment should be continued for 24 to 48 hours                                                                                                                                             |
| Pneumonia                                                     | of diseases due to oxytetracycline-susceptible organisms as follows: Pneumonia and shipping fever complex associated with Pasteurella spp.,                                                  |
| Pasteurella                                                   | follows: Pneumonia and shipping fever complex associated with Pasteurella spp., Haemophilus spp., and Klebsiella spp., foot-rot and                                                          |
| Haemophilus                                                   | and shipping fever complex associated with Pasteurella spp., Haemophilus spp., and Klebsiella spp., foot-rot and diphtheria caused                                                           |
| Spherophorus                                                  | and Klebsiella spp., foot-rot and diphtheria caused by Spherophorus necrophorus, bacterial enteritis (scours) caused by Escherichia coli,                                                    |
| Streptococcus                                                 | and  Streptococcus  spp.                                                                                                                                                                     |
| Discontinue                                                   | Discontinue  treatment at least 18 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella  multocida, and leptospirosis caused by Leptospira pomona.                                                       |
| Discontinue                                                   | Discontinue  treatment at least 26 days before slaughter.                                                                                                                                    |
| Pasteurella                                                   | of pneumonia and shipping fever complex associated with Pasteurella spp., Haemophilus spp., Klebsiella spp., foot-rot and diphtheria                                                         |
| Haemophilus                                                   | and shipping fever complex associated with Pasteurella spp., Haemophilus spp., Klebsiella spp., foot-rot and diphtheria caused by                                                            |
| Klebsiella                                                    | fever complex associated with Pasteurella spp., Haemophilus spp., Klebsiella spp., foot-rot and diphtheria caused by Spherophorus necrophorus,                                               |
| Spherophorus                                                  | spp., Klebsiella spp., foot-rot and diphtheria caused by Spherophorus necrophorus, bacterial enteritis (scours) caused by Escherichia coli,                                                  |
| Severe                                                        | Severe foot-rot and the severe forms of the indicated                                                                                                                                        |
| Treatment                                                     | Treatment should be continued 24 to 48 hours following                                                                                                                                       |
| Discontinue                                                   | Discontinue  treatment at least 19 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | of pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                                    |
| Haemophilus                                                   | and  Haemophilus  spp.                                                                                                                                                                       |
| Spherophorus                                                  | ; foot-rot and diphtheria caused by  Spherophorus necrophorus; bacterial enteritis (scours) caused by Escherichia coli;                                                                      |
| Pasteurella                                                   | colibacillosis) caused by Escherichia coli; pneumonia caused by Pasteurella  multocida; and leptospirosis caused by Leptospira pomona.                                                       |
| Pasteurella                                                   | gallisepticum and Escherichia coli; fowl cholera caused by Pasteurella multocida; infectious sinusitis caused by Mycoplasma gallisepticum; and                                               |
| Treatment                                                     | Treatment should continue for 24 to 48 hours beyond                                                                                                                                          |
| Pneumonia                                                     | of diseases due to oxytetracycline-susceptible organisms as follows: Pneumonia  and shipping fever complex associated with Pasteurella spp.                                                  |
| Pasteurella                                                   | follows: Pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                              |
| Haemophilus                                                   | and  Haemophilus spp., foot-rot and diphtheria caused by Fusobacterium necrophorum,                                                                                                          |
| Fusobacterium                                                 | and Haemophilus spp., foot-rot and diphtheria caused by  Fusobacterium necrophorum, bacterial enteritis (scours) caused by Escherichia coli,                                                 |
| Streptococcus                                                 | and  Streptococcus  spp.                                                                                                                                                                     |
| Discontinue                                                   | Discontinue  treatment at least 15 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella  multocida, and leptospirosis caused by Leptospira pomona.                                                       |
| Discontinue                                                   | Discontinue  treatment at least 22 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | of pneumonia and shipping fever complex associated with Pasteurella  spp., Haemophilus spp., or Klebsiella spp.                                                                              |
| Haemophilus                                                   | and shipping fever complex associated with Pasteurella spp., Haemophilus  spp., or Klebsiella spp.                                                                                           |
| Pasteurella                                                   | colibacillosis) caused by Escherichia coli, pneumonia caused by Pasteurella  multocida, and leptospirosis caused by Leptospira pomona.                                                       |
| Discontinue                                                   | Discontinue  treatment at least 20 days prior to slaughter.                                                                                                                                  |
| Pasteurella                                                   | bacterial pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                             |
| Discontinue                                                   | Discontinue  treatment at least 22 days before slaughter.                                                                                                                                    |
| Pasteurella                                                   | bacterial pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                             |
| Spherophorus                                                  | ; foot-rot and diptheria caused by  Spherophorus necrophorus; bacterial enteritis (scours) caused by Escherichia coli;                                                                       |
| Discontinue                                                   | Discontinue  treatment at least 18 days before slaughter.                                                                                                                                    |
| Pasteurella                                                   | follows: pneumonia and shipping fever complex associated with Pasteurella  spp.                                                                                                              |
| Haemophilus                                                   | and  Haemophilus  spp.                                                                                                                                                                       |
| Fusobacterium                                                 | ; foot rot and diphtheria caused by  Fusobacterium necrophorum; bacterial enteritis (scours) caused by Escherichia coli;                                                                     |
| Treatment                                                     | Treatment should be continued 24 to 48 hours following                                                                                                                                       |
| Discontinue                                                   | Discontinue  use at least 19 days prior to slaughter.                                                                                                                                        |
| Oxytetracycline                                               | Oxytetracycline  hydrochloride with lidocaine injection.                                                                                                                                     |
| Streptococcus                                                 | of the urinary tract caused by Hemolytic staphylococcus, Streptococcus  spp., Bacterial pulmonary infections caused by Brucella bronchiseptica,                                              |
| Streptococcus                                                 | of the urinary tract caused by Hemolytic staphylococcus, Streptococcus  spp., Bacterial pulmonary infections caused by Brucella bronchiseptica,                                              |
| Brucella                                                      | albus,  Brucella  bronchiseptica, Streptococcus spp.                                                                                                                                         |
| Streptococcus                                                 | albus, Brucella bronchiseptica,  Streptococcus  spp.                                                                                                                                         |
| Therapy                                                       | Therapy should be continued for at least 24 hours                                                                                                                                            |
| Oxytetracycline                                               | Oxytetracycline  and flunixin.                                                                                                                                                               |
| Pasteurella                                                   | For the treatment of bacterial pneumonia associated with  Pasteurella  spp.                                                                                                                  |
| Discontinue                                                   | Discontinue treatment at least 21 days prior to slaughter                                                                                                                                    |
| Oxytocin                                                      | Oxytocin .                                                                                                                                                                                   |
| Oxytocin                                                      | Oxytocin may be used as a uterine contractor to                                                                                                                                              |
| Pegbovigrastim                                                | Pegbovigrastim .                                                                                                                                                                             |
| Repeat                                                        | Repeat  dosage in 48 hours.                                                                                                                                                                  |
| Repeat                                                        | Repeat  dosage in 48 hours.                                                                                                                                                                  |
| Repeat                                                        | Repeat  dosage in 48 hours.                                                                                                                                                                  |
| Repeat                                                        | Repeat  dosage in 48 hours.                                                                                                                                                                  |
| Actinomyces                                                   | (A) Treatment of bacterial pneumonia (Streptococcus spp.,  Actinomyces pyogenes, Staphylococcus aureus); upper respiratory infections such as                                                |
| Cattle                                                        | (2)  Cattle , sheep, swine, and horses&#8212;(i) Amount.                                                                                                                                     |
| Pasteurella                                                   | sheep for bacterial pneumonia (shipping fever) caused by Pasteurella multocida; swine for erysipelas caused by Erysipelothrix rhusiopathiae;                                                 |
| Discontinue                                                   | Discontinue treatment for the following number of days before                                                                                                                                |
| Horses                                                        | Horses &#8212;3,000 units per pound of body weight once                                                                                                                                      |
| Pentazocine                                                   | Pentazocine .                                                                                                                                                                                |
| Pentobarbital                                                 | Pentobarbital .                                                                                                                                                                              |
| Phenylbutazone                                                | Phenylbutazone .                                                                                                                                                                             |
| Limit                                                         | Limit  intravenous administration to 2 successive days.                                                                                                                                      |
| Limit                                                         | Limit intravenous administration to not more than 5 successive                                                                                                                               |
| Cattle                                                        | Cattle and horses: 25 milligrams; swine: 5 milligrams; sheep:                                                                                                                                |
| Treatment                                                     | Treatment may be repeated in 1 to 4 weeks,                                                                                                                                                   |
| Pralidoxime                                                   | Pralidoxime  powder for injection.                                                                                                                                                           |
| Praziquantel                                                  | Praziquantel .                                                                                                                                                                               |
| Taenia                                                        | For removal of canine cestodes Dipylidium caninum,  Taenia pisiformis, and Echinococcus granulosus, and removal and control                                                                  |
| Echinococcus                                                  | of canine cestodes Dipylidium caninum, Taenia pisiformis, and Echinococcus  granulosus, and removal and control of canine cestode                                                            |
| Taenia                                                        | For removal of feline cestodes Dipylidium caninum and  Taenia  taeniaeformis.                                                                                                                |
| Dosage                                                        | Dosage may be repeated in 12 to 24 hours                                                                                                                                                     |
| Sterile                                                       | Sterile  prednisone suspension.                                                                                                                                                              |
| Treatment                                                     | Treatment  may be continued with an orally administered dose.                                                                                                                                |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Promazine                                                     | Promazine .                                                                                                                                                                                  |
| Propiopromazine                                               | Propiopromazine .                                                                                                                                                                            |
| Propofol                                                      | Propofol .                                                                                                                                                                                   |
| Prostalene                                                    | Prostalene .                                                                                                                                                                                 |
| Pyrilamine                                                    | Pyrilamine .                                                                                                                                                                                 |
| Dosage                                                        | Dosage may be repeated every 6 to 12 hours                                                                                                                                                   |
| Dosage                                                        | Dosage may be repeated every 6 to 12 hours                                                                                                                                                   |
| Robenacoxib                                                   | Robenacoxib .                                                                                                                                                                                |
| Romifidine                                                    | Romifidine .                                                                                                                                                                                 |
| Selenium                                                      | Selenium  and vitamin E.                                                                                                                                                                     |
| Calves                                                        | Calves : 2.5 to 3.75 milliliters per 100 pounds                                                                                                                                              |
| Ewes                                                          | Ewes : 2.5 milliliters per 100 pounds.                                                                                                                                                       |
| Calves                                                        | Calves , lambs, and ewes: prevention and treatment of                                                                                                                                        |
| Calves                                                        | Calves : Discontinue use 30 days before treated calves                                                                                                                                       |
| Lambs                                                         | Lambs , ewes, sows, or pigs: Discontinue use 14                                                                                                                                              |
| Discontinue                                                   | Discontinue use 30 days before treated cattle are slaughtered                                                                                                                                |
| Newborn                                                       | Newborn  lambs: 1 milliliter.                                                                                                                                                                |
| Baby                                                          | Baby pigs: 1 milliliter (or treat the sow during                                                                                                                                             |
| Baby                                                          | Baby pigs: an aid in the prevention and treatment                                                                                                                                            |
| Discontinue                                                   | Discontinue use 14 days before treated animals are slaughtered                                                                                                                               |
| Sometribove                                                   | Sometribove  zinc suspension.                                                                                                                                                                |
| Safety                                                        | Safety to replacement bulls born to treated dairy cows                                                                                                                                       |
| Inject                                                        | Inject  subcutaneously.                                                                                                                                                                      |
| Avoid                                                         | Avoid injections within 2 weeks of expected slaughter to                                                                                                                                     |
| Use                                                           | Use care to differentiate increased body temperature due to                                                                                                                                  |
| Spectinomycin                                                 | Spectinomycin  dihydrochloride injection.                                                                                                                                                    |
| Abbott                                                        | Abbott ) or the same antibiotic substance produced by                                                                                                                                        |
| Turkey                                                        | (i)  Turkey poults at the rate of 5 milligrams per                                                                                                                                           |
| Treatment                                                     | Treatment  may be continued for 4 days.                                                                                                                                                      |
| Spectinomycin                                                 | Spectinomycin  sulfate.                                                                                                                                                                      |
| Pasteurella                                                   | bovine respiratory disease (pneumonia) associated with Mannheimia haemolytica, Pasteurella  multocida, and Histophilus somni.                                                                |
| Histophilus                                                   | (pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus  somni.                                                                                           |
| Sulfachlorpyridazine                                          | Sulfachlorpyridazine .                                                                                                                                                                       |
| Sulfadimethoxine                                              | Sulfadimethoxine .                                                                                                                                                                           |
| Proteus                                                       | when caused by Streptococci, Staphylococci, Escherichia, Salmonella, Klebsiella, Proteus , or Shigella organisms sensitive to sulfadimethoxine, and                                          |
| Pasteurella                                                   | (shipping fever complex) and bacterial pneumonia associated with Pasteurella  spp.                                                                                                           |
| Sulfaethoxypyridazine                                         | Sulfaethoxypyridazine .                                                                                                                                                                      |
| Treatment                                                     | Treatment should not exceed a total of 5 consecutive                                                                                                                                         |
| Withdraw                                                      | Withdraw  medication from cattle 10 days prior to slaughter.                                                                                                                                 |
| Sulfomyxin                                                    | Sulfomyxin .                                                                                                                                                                                 |
| Sulfomyxin                                                    | Sulfomyxin  for injection is sterile.                                                                                                                                                        |
| Bacillus                                                      | the antibiotic substance produced by the growth of Bacillus polymyxa or is the same substance produced by                                                                                    |
| Thiamylal                                                     | Thiamylal .                                                                                                                                                                                  |
| Thiopental                                                    | Thiopental  injectable dosage forms.                                                                                                                                                         |
| Thiopental                                                    | Thiopental  powder for injection.                                                                                                                                                            |
| Thiopental                                                    | Thiopental  and pentobarbital powder for injection.                                                                                                                                          |
| Tildipirosin                                                  | Tildipirosin .                                                                                                                                                                               |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating                                              |
| Histophilus                                                   | (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating dairy cattle; and                                                       |
| Cattle                                                        | Cattle intended for human consumption must not be slaughtered                                                                                                                                |
| Tilmicosin                                                    | Tilmicosin .                                                                                                                                                                                 |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella  multocida, and Histophilus somni.                                                                      |
| Histophilus                                                   | (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus  somni.                                                                                                 |
| Mannheimia                                                    | treatment of ovine respiratory disease (ORD) associated with Mannheimia  (P.)                                                                                                                |
| Tiludronate                                                   | Tiludronate .                                                                                                                                                                                |
| Tolazoline                                                    | Tolazoline .                                                                                                                                                                                 |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Trenbolone                                                    | Trenbolone  acetate and estradiol.                                                                                                                                                           |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Effectiveness                                                 | Effectiveness and animal safety in veal calves have not                                                                                                                                      |
| Effectiveness                                                 | Effectiveness and animal safety in veal calves have not                                                                                                                                      |
| Trenbolone                                                    | Trenbolone  acetate and estradiol benzoate.                                                                                                                                                  |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Usual                                                         | Usual  dose is 12 to 20 mg.                                                                                                                                                                  |
| Triflupromazine                                               | Triflupromazine .                                                                                                                                                                            |
| Trimethoprim                                                  | Trimethoprim  and sulfadiazine.                                                                                                                                                              |
| Streptococcus                                                 | alimentary tract infections, and acute septicemia due to Streptococcus  zooepidemicus.                                                                                                       |
| Tulathromycin                                                 | Tulathromycin .                                                                                                                                                                              |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella  multocida,                                                                                             |
|                                                               |               Histophilus somni, and Mycoplasma bovis.                                                                                                                                       |
| Histophilus                                                   | disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus  somni, and Mycoplasma bovis.                                                                       |
| Fusobacterium                                                 | of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium  necrophorum and Porphyromonas levii.                                                                        |
| Porphyromonas                                                 | rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas  levii.                                                                                       |
| Pasteurella                                                   | bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella  multocida,                                                                                             |
|                                                               |               Histophilus somni, and Mycoplasma bovis.                                                                                                                                       |
| Histophilus                                                   | disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus  somni, and Mycoplasma bovis.                                                                       |
| Bordetella                                                    | disease (SRD) associated with Actinobacillus pleuropneumoniae, P. multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for                          |
| Haemophilus                                                   | associated with Actinobacillus pleuropneumoniae, P. multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control                            |
| Swine                                                         | Swine intended for human consumption must not be slaughtered                                                                                                                                 |
| Tylosin                                                       | Tylosin .                                                                                                                                                                                    |
| Pasteurella                                                   | respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Arcanobacterium pyogenes; foot rot (necrotic pododermatitis)                               |
| Arcanobacterium                                               | fever, pneumonia) usually associated with Pasteurella multocida and Arcanobacterium pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria                                         |
| Fusobacterium                                                 | rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium  necrophorum and metritis caused by A. pyogenes.                                                                   |
| Cattle                                                        | Cattle intended for human consumption must not be slaughtered                                                                                                                                |
| Pasteurella                                                   | caused by Mycoplasma hyosynoviae; swine pneumonia caused by Pasteurella  spp.                                                                                                                |
| Adverse                                                       | Adverse reactions, including shock and death may result from                                                                                                                                 |
| Swine                                                         | Swine intended for human consumption must not be slaughtered                                                                                                                                 |
| Pasteurella                                                   | caused by Staphylococci spp., hemolytic Streptococci spp., and Pasteurella  multocida.                                                                                                       |
| Xylazine                                                      | Xylazine .                                                                                                                                                                                   |
| Cervidae                                                      | Do not use in  Cervidae less than 15 days before or during the                                                                                                                               |
| Yohimbine                                                     | Yohimbine .                                                                                                                                                                                  |
| Cervidae                                                      | free ranging or confined members of the family Cervidae  (deer and elk).                                                                                                                     |
| Zeranol                                                       | Zeranol .                                                                                                                                                                                    |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Implant                                                       | Implant  subcutaneously in ear only.                                                                                                                                                         |
| Safety                                                        | Safety and effectiveness have not been established in veal                                                                                                                                   |
| Zinc                                                          | Zinc  gluconate.                                                                                                                                                                             |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                           |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2018-01-10 | (B) Two-dose regimen: For the treatment of acute metritis (0-to 10-days postpartum) associated with bacterial organisms susceptible to ceftiofur in lactating dairy cattle.                                                                                                                       |
| 2018-01-03 | (1) 1- to 3-day-old chickens.                                                                                                                                                                                                                                                                     |
| 2018-01-03 | For subcutaneous injection in the neck of 1- to 3-day-old chickens.                                                                                                                                                                                                                               |
| 2018-05-20 | Administer by intramuscular injection as follows: Dogs: 0.25 to 1 mg; cats: 0.125 to 0.5 mg; horses: 5 to 20 mg.                                                                                                                                                                                  |
| 2018-10-12 | 25 mg as an intramuscular injection either once or twice at a 10- to 12-day interval.                                                                                                                                                                                                             |
| 2018-01-03 | For 1- to 3-day old turkey poults.                                                                                                                                                                                                                                                                |
| 2051-02-01 | For use only in gilts over 51/2 months of age and weighing at least 85 kilograms (187 pounds).                                                                                                                                                                                                    |
| 2018-01-04 | For the treatment of infectious sinusitis in turkeys, 1/4 to 1/2 milliliter of the drug is injected directly into each swollen sinus depending upon the age of the bird and the severity of the condition.                                                                                        |
| 2018-03-05 | The drug is used in beef cattle, beef calves, nonlactating dairy cattle, and dairy calves as follows: 3 to 5 milligrams of oxytetracycline hydrochloride per pound of body weight per day; 5 milligrams per pound of body weight per day for treatment of severe forms of the indicated diseases. |
| 2018-01-20 | (2) Each mL of solution packaged in 5-mL ampules or 20-, 30-, or 50-mL vials contains 100 mg polysulfated glycosaminoglycan.                                                                                                                                                                      |
| 2006-01-03 | Administer intravenously in a dosage of 21/2 to 5 mg per pound of body weight, initially for shock and shock-like states, followed by equal maintenance doses at 1-, 3-, 6-, or 10-hour intervals as determined by the condition of the animal.                                                   |
| 2018-01-03 | (4) Administer single injection of 0.1 milliliter (10 milligrams) subcutaneously in nape of neck of 1- to 3-day-old turkey poults as an aid in control of airsacculitis associated with M. meleagridis sensitive to spectinomycin.                                                                |
| 2018-01-02 | Usually 1/2 to 2/3 the normal amount is adequate.                                                                                                                                                                                                                                                 |
| 2018-02-03 | Usually 1/2 to 2/3 the normal amount is adequate.                                                                                                                                                                                                                                                 |
| 2018-02-03 | Usually 1/2 to 2/3 the normal amount is adequate.                                                                                                                                                                                                                                                 |
| 2018-12-24 | Administer 3 to 5 mg/lb of body weight by intramuscular injection at 12- to 24-hour intervals.                                                                                                                                                                                                    |
| 2018-01-02 | (B) Mule deer (Odocoileus hemionus), sika deer (Cervus nippon), and white-tailed deer (Odocoileus virginianus): 1 to 2 mg/lb.                                                                                                                                                                     |
| 2018-02-04 | (C) Fallow deer (Dama dama): 2 to 4 mg/lb.                                                                                                                                                                                                                                                        |
| 2018-01-03 | Intratesticular injection for chemical sterilization of 3- to 10-month-old male dogs.                                                                                                                                                                                                             |


